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ABSTRACT 
 
Inositol dehydrogenase (IDH) catalyzes the oxidation of myo-inositol to scyllo-
inosose using NAD
+
 as the coenzyme. IDH-related genes (Lp_iolG1 to Lp_iolG4) from 
Lactobacillus plantarum WCSF1 and (Lc_iolG1 and Lc_iolG2) from Lactobacillus casei 
BL23 were cloned into the vector pQE-80L, expressed in E. coli host cells and the 
proteins were purified to homogeneity. IDH activity of the purified enzymes was 
explored with myo-inositol and other structurally related compounds. It was found that 
IDH-related enzymes from L. plantarum WCSF1 did not exhibit any activity with tested 
substrates but, LcIDH1 and LcIDH2 from L. casei BL23 showed activity with myo-
inositol and other related compounds. pH-rate profile studies have demonstrated the 
optimum pH for the reactions catalyzed by the active enzymes. Steady-state kinetics of 
the active enzymes was performed as with IDH from Bacillus subtilis (BsIDH), revealing 
that LcIDH1 is a myo-inositol dehydrogenase and LcIDH2 is a scyllo-inositol 
dehydrogenase. Both LcIDH1 and LcIDH2 are observed to be NAD
+
-dependent. Kinetic 
isotopic effect experiments for LcIDH1 have demonstrated that the chemical step in the 
reaction is partly rate-limiting. Substrate spectrum of LcIDH1 and LcIDH2 was explored 
and compared to BsIDH. Finally, a multiple sequence alignment of IDH-related enzymes 
was performed and the proposed consensus sequence motifs were considered to 
understand the activity differences between these enzymes. 
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1. INTRODUCTION 
1.1  Inositol and its importance 
  Inositol (cyclohexanehexol) exists in nine possible stereoisomers (Figure 1.1), 
myo-inositol, scyllo-inositol, D-chiro-inositol, L-chiro-inositol, muco-inositol, allo-
inositol, epi-inositol, cis-inositol and neo-inositol (1). Among these isomers, myo-, D-
chiro- scyllo-, L-chiro-, muco-, and neo- inositols are found in nature, while allo-, epi-, 
and cis- inositols can be obtained by chemical synthesis only. D-chiro- & L-chiro-
inositols are enantiomers while other isomers are optically inactive (2). myo-Inositol (cis-
1,2,3,5-trans-4,6-cyclohexanehexol), is the predominant form of inositol in nature (3). 
 
 
 
Figure 1.1: Structure and nomenclature of possible stereoisomers of inositol. 
myo-inositol and its phosphate derivatives play an important role as secondary 
messenger molecules in diverse cellular activities, such as cell growth, apoptosis, cell 
migration, cell differentiation, stress response, seed germination, gene expression, 
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hormone function, protein trafficking etc, (4-10). Recently, D-chiro-inositol has been 
identified as a potential drug for the treatment of type-2-diabetes and polycystic ovary 
syndrome (11, 12). Phytic acid, or inositol hexakisphosphate is the principal storage form 
of phosphorus in plant tissues(13, 14). It is also found in high concentrations in many 
food items; including cereal grains, nuts, and seeds. Phytic acid is a metal chelator that 
can suppress the damage caused by metal-catalyzed redox reactions, making it a natural 
antioxidant (15). myo-inositol in the form of phytic acid has been proposed as a possible 
agent in the treatment of colon-cancer (16). 
 
1.2  Inositol catabolism in bacteria 
  Inositol metabolism in eukaryotes is not discussed in this thesis as this work is 
entirely related to bacterial species. However, it has been reported that eukaryotic myo-
inositol catabolic pathway is different from that which occurs in bacteria (17). myo-
Inositol catabolism was reported for the first time in Aerobacter aerogenes (reclassified 
as Enterobacter aerogenes/Klebsiella mobilis) (18). Later, it was Anderson et al., who 
demonstrated that acetyl-CoA, dihydroxyacetone phosphate (DHAP) and carbon dioxide 
are the end products of myo-inositol degradation in A. aerogenes (19). Further, it was 
reported that several microorganisms, including Cryptococcus melibiosum (20), Rizobium 
leguminosarum by. viciae (21), Bacillus subtilis (22), Sinorhizobium meliloti (23), 
Salmonella enteric serovar Typhimurium (24), Sinorhizobium fredii (25), 
Corynebacterium glutamicum (26) and Lactobacillus casei strain BL23 (27) are able to 
utilize myo-inositol as the sole carbon source for their metabolism.  
  However, a detailed myo-inositol catabolic pathway was reported from B. subtilis 
(22). In this organism, the iol divergon containing iolABCDEFGHIJ, iolRS, and iolT 
operons (clusters of genes) are involved in myo-inositol catabolism. Furthermore, it was 
demonstrated that B. subtilis can also utilize D-chiro-inositol as the carbon source (28). 
Recently, it was demonstrated that B. subtilis can also grow on scyllo-inositol as a sole 
carbon source and that this organism has two different scyllo-inositol dehydrogenase 
enzymes (29). The enzymes encoded by iolX and iolW (earlier called as yisS and yvaA 
respectively) catalyze the reversible oxidation of scyllo-inositol to scyllo-inosose using 
NAD
+
 and NADP
+
 as coenzymes respectively. Inositol catabolic pathways proposed for 
A. aerogenes, B. subtilis are indicated in Figure 1.2. 
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Figure 1.2: The proposed inositol catabolic pathway in bacteria. The proposed pathways from A. 
aerogenes, B. subtilis and L. casei BL23 are represented in colors. The pathway for B.subtilis is represented 
in all black; the pathway for A. aerogenes is indicated in green and the iolK pathway for L. casei BL23 is 
indicated in blue. The enzyme catalyzing each reaction is indicated in red. Compounds: THcHDO = 3D-(3, 
5/4)-trihydroxycyclo hexane-1, 2-dione; 5-DG = 5-deoxy-glucuronic acid; DKG = 5-deoxy-2-keto-gluconic 
acid; DKGP = 5-deoxy-2-keto-gluconic acid-6-phosphate; DHAP = dihydroxy acetone phosphate; MSA = 
malonic semialdehyde. 
 
   As reported, B. subtilis takes up myo-inositol and other related compounds with 
the help of inositol transporters, IolT and IolF (30). Once the inositol is inside the cell, 
IolG catalyzes the first step of this catabolic pathway, the oxidation of myo-inositol to 
scyllo-inosose sometimes called as 2-keto-myo-inositol, and D-chiro-inositol to 1-keto-D-
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chiro-inositol. IolI catalyzes the conversion of 1-keto-D-chiro-inositol to scyllo-inosose. 
IolX and IolW catalyze the conversion of scyllo-inositol to scyllo-inosose (29). The 
second step of the pathway is catalyzed by IolE, a 2-keto-myo-inositol dehydratase (31). 
According to Anderson et al., the product of the second step, 3D-(3, 5/4)-
trihydroxycyclohexane-1, 2-dione, (THcHDO) [earlier called as D-2, 3-diketo-4-deoxy-
epi-inositol], isomerizes to an intermediate (indicated in green in Figure 1.2) by keto-
enol tautomerization and leads to formation of 2-deoxy-5-keto-D-gluconic acid (DKG). 
But it was proposed to be different in B. subtilis myo-inositol catabolic pathway in which, 
THcHDO gets hydrolyzed to 5-deoxy-glucuronic acid (5-DG) catalyzed by IolD, a 
hydrolase. Isomerization of 5-DG to DKG is a fourth reaction catalyzed by IolB, an 
isomerase.  
  From the fifth reaction, the pathways in both A. aerogenes and B. subtilis are 
similar. IolC, a kinase, phosphorylates DKG to from 2-deoxy-5-keto-D-gluconic acid-6-
phosphate (DKGP) in the presence of ATP. DKGP is cleaved into DHAP and malonic 
semialdehyde (MSA) by the action of IolJ, an aldolase. The final step of the pathway is 
catalyzed by a malonic semialdehyde decarboxylase, that was reported to be encoded by 
the product of  iolA (32). The function of IolH has not been characterized but it was 
found that IolH is paralogous to IolE and IolI suggesting that IolH may act as either a 
dehydratase or an isomerase. However, it was demonstrated that IolH did not possess the 
dehydratase activity. Finally, it was demonstrated that iolS from iolRS operon encodes a 
pyridoxal reductase (30), which was earlier reported to be homologous to pyridoxal 
reductase of Schizosaccharomyces pombe (33). 
  The iol operon similar to B. subtilis has been identified in L. casei BL23 (27). 
However, some of the genes such as iolI, iolH, iolS and one of the inositol transporter 
genes, iolF are not present in the iol operon of L. casei BL23. But the presence of iolK, 
predicted to be a malonic semialdehyde decarboxylase, suggested that this organism may 
have two different pathways for malonic semialdehyde metabolism. The additional iolK 
pathway in L. casei BL23 is indicated in blue in Figure 1.2. Moreover, L. casei BL23 has 
two IDH-related genes, iolG1 and iolG2 in its operon.  
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1.3 Lactic acid bacteria and their importance 
  Lactic acid bacteria are a group of gram-positive, non-sporulating, non-respiring 
cocci (round shaped), or bacilli (rod shaped) that produce lactic acid during the 
fermentation of different carbohydrates (34). Lactobacillus, Leuconostoc, Pediococcus, 
Lactococcus and Streptococcus forms the main genera of this group. However, other 
organisms such as Aerococcus, Carnobacterium, Enterococcus, Oenococcus, 
Sporolactobacillus, tetragenococcus and Weisella are considered as the principle lactic 
acid bacteria based on their practical application in food and fermentation industries. 
Lactic acid bacteria are called either homofermentative or heterofermentative bacteria 
based on their method of carbohydrate metabolism. Homofermentative bacteria follow 
the Embden-Meyerhof-Parnas (EMP) pathway to metabolize sugars and produce high 
amounts of lactic acid (>85%) as the sole end product, while heterofermentative bacteria 
follow the pentose-phosphate pathway, alternatively called the phosphoketolase pathway 
or the phosphogluconate pathway and produces CO2, ethanol/acetate and relatively less 
amount of lactic acid (34). 
  The genus Lactobacillus constitutes the largest group among lactic acid bacteria 
with over 100 species and subspecies. These microbes can be found in a variety of 
ecological niches such as plants, animals, raw milk and fermented food materials. Earlier, 
the Lactobacillus group was divided into three phylogenetic groups, the Lactobacillus 
casei-Pediococcus, Lactobacillus delbrueckii and Leuconostoc group, based on their 
16S/23S rRNA gene sequence analysis (35). Later, the group L. delbrueckii was renamed 
as L. acidophilus and the L. casei-Pediococcus group was divided into L. plantarum, L. 
casei, L. reuteri, L. bcuchneri and L. salivarius groups (36). Lactobacillus species have 
been associated with food fermentation and dairy industries for many years. The ability to 
metabolize many sugars results in the production of several natural compounds, including 
organic acids (lactic acid, acetic acid, formic acid, phenyllactic acid, caproic acid), 
carbon dioxide, hydrogen peroxide, diacetyl, ethanol, bacteriocins, reuterin and 
reutericyclin. These compounds have been reported to have antimicrobial properties 
which help in preventing the growth of other bacteria and fungi (37, 38). 
  Probiotics are defined as “live microorganisms which, when administered in 
adequate amounts, confer health benefit on the host” (39). In order to consider a 
microorganism as a probiotic, it must have certain functional properties for example, it 
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must show tolerance to the acidic environment of human gut, adherence to epithelial 
surfaces, persistence in the human gastrointestinal (GI) tract, immune stimulation, 
antagonistic activity toward intestinal pathogens and the capacity to stabilize and 
modulate the intestinal microbes (40, 41). Probiotics must be non-pathogenic and non-
toxic and should not carry acquired, genetically exchangeable antibiotic resistance.  
  Furthermore, it has been reported that probiotic Lactobacillus species have many 
beneficial effects on animal and human health. It has been demonstrated that LAB 
fermented milk and yoghurt supplemented with L. bulgaricus and Streptococcus 
thermophilus cultures have anti-mutagenic effects; that is, these bacteria degrade the 
harmful chemical mutants that are produced as a result of metabolism (42, 43). Studies on 
animal models and humans have demonstrated that probiotic Lactobacillus species such 
as L. acidophilus and L. casei (44, 45), L. cremori (46), L. bulgaricus (47), and 
Bifidobacteria bifidum (48) have been observed to reduce the serum cholesterol levels 
and decrease the risk of heart diseases. Consumption of sour milk fermented by L. 
helveticus and Saccharomyces cerevisiae cultures resulted in significant reduction of 
blood pressure in hypertensive patients (49-51), and many more applications of 
Lactobacillus have been reported. 
 
1.3.1 Lactobacillus plantarum WCFS1 
  Lactobacillus plantarum WCFS1 is a microaerophilic, heterofermentative 
organism, usually found as a natural inhabitant of fermented vegetables and  meat  
products (52). The strain WCFS1 is a single colony isolate of L. plantarum NCIMB8826, 
which was initially isolated from human saliva. The whole genome sequence of this 
organism has been determined. It contains two small, cryptic plasmids (2365 bp and 1917 
bp) and a larger plasmid (36069 bp) encoding all genes involved in conjugal plasmid 
transfer and several other functions. The genome contains 3052 predicted protein coding 
genes and the putative biological functions were assigned to 2120 (70%) of these 
predicted gene products based on the sequence homology with other bacteria.  
  Presence of the 3.3 Mbp genome (largest among lactic acid bacteria), and 
majority of the predicted proteins that are related to various sugar transporters and sugar 
metabolism suggests that L. plantarum WCFS1 is able to ferment different sugars and 
can survive in various environmental habitats. Moreover, it has been reported that this 
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organism along with other Lactobacilli can survive passage through the stomach and is 
able to live for at least a week in the human GI tract and can adhere to epithelial surfaces 
of the GI tract. This property makes them to use as the vehicles for the delivery of active 
pharmaceutics, antibodies, enzymes and vaccines (53, 54). In contrast to other vaccine 
carriers such as Salmonella, E. coli, and Vaccinia etc., Lactobacilli are considered highly 
safe for these purposes.  
  myo-Inositol catabolism has not been reported for this organism. Although, the iol 
operon looks incomplete, it consists of four predicted IDH-related genes (Lp_iolG1 to 
Lp_iolG4). A diagram showing the iol operon of L. plantarum WCFS1 is indicated in 
Figure 1.3. In this thesis, the products of these genes are represented as LpIDH1 to 
LpIDH4 respectively.  
 
1.3.2  Lactobacillus casei BL23 
  L. casei BL23 is a probiotic strain of genus Lactobacillus. It was identified while 
trying to obtain a plasmid free L. casei ATCC 393 (reclassified as L. zeae) (55). It is also 
a gram-positive, heterofermentative lactic acid producing bacteria. Its complete genome 
sequence reveals that it has a single circular chromosome of 3.08 Mbp (55). The genome 
of L. casei BL23 has an extra 12.8 K bp of DNA, compared to L. casei ATCC 334 and it 
is involved in myo-inositol catabolism (27). Based on these findings, the myo-inositol 
catabolic pathway has been proposed (Figure 1.2). The iol operon of this organism, as 
shown in Figure 1.3, consists of two IDH-related genes (Lc_iolG1 and Lc_iolG2).  
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Figure 1.3: The iol operon showing the organization of the genes involved in myo-inositol catabolism. 
IDH-related genes are indicated in red. The image is generated using ChemDraw Pro 12.0 Version based 
on the information reported in Appl. Environ. Microbiol. (2000), 73: 3850-3858. 
 
 
1.4   BsIDH as a model enzyme 
 In B. subtilis, IDH is encoded by iolG and hereafter this enzyme is called as 
BsIDH throughout this thesis.  BsIDH (EC 1.1.1.18) belongs to the oxidoreductase class 
of enzymes because it catalyzes the oxidation-reduction reaction by transferring a hydride 
group between the substrate and the coenzyme, NAD
+
. BsIDH was first isolated and 
characterized by Ramaley et al., in 1979 (56). The active enzyme is a homotetramer with 
an apparent molecular weight of 160 kDa and each monomer of 40 kDa. The pH-rate 
profile indicated that the maximum activity for the forward reaction occurs at pH 9.0 and 
for the reverse reaction occurs at pH 7.0. Our lab has also studied the biochemical and 
mechanistic features of this enzyme to a great detail in collaborating with Dr. David A. R. 
Sanders lab and confirmed that BsIDH is an NAD
+
-dependent enzyme and catalyzes the 
oxidation of the C2 axial hydroxyl group of myo-inositol to form scyllo-inosose, and 
simultaneous reduction of NAD
+
 to NADH by transferring the C2 equatorial hydride of 
myo-inositol to the C4 of  the nicotinamide ring of NAD
+
, which is the first step in the 
myo-inositol catabolism for B. subtilis (Scheme 1.1) (56, 57).  
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 Kinetic studies have demonstrated that the reaction catalyzed by BsIDH follows a 
sequentially ordered Bi-Bi mechanism (56, 58). The enzyme shows a broad substrate 
spectrum and at the same time it is highly stereoselective between the substrates (57, 59). 
This enzyme predominantly oxidizes myo-inositol and can also accept other related 
compounds such as D-glucose and D-xylose as its substrates, but shows no activity with 
scyllo-inositol (56). Previous results from our laboratory have revealed that 4-O-
substituted myo-inositol and 6-O-substituted D-glucose derivatives were also substrates 
for BsIDH (60). In addition, it shows trace activity with D-ribose and D-fructose, but 
cannot oxidize compounds such as D-galactose, D-sorbitol, D-mannose, D-mannitol, 
GDP-D-mannose, scyllo-inosose, ADP-D-glucose, D-mannose-6-phosphate, CDP-D-
glucose, D-glucose-6-phosphate, myo-inositol-4-O-phosphate, D-glucosamine, 2-deoxy-
D-glucose-6-phosphate, D-erythrose, D-erythritol and N-acetyl-D-glucosamine (56, 61). 
Recently it is was reported that, BsIDH can also oxidize D-chiro-inositol (28), and 
pinitol, (3-O-methyl-D-chiro-inositol) (62). 
 
 
 
Scheme 1.1: Reaction catalyzed by BsIDH 
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Figure 1.4: Structure of BsIDH (PDB code: 3NT4). The N-terminal domain with bound NAD
+
 is 
indicated in red and the C-terminal domain with myo-inositol (MI) in the active site is shown in yellow. 
Active site residues, (K97, D172 and H176) and NAD
+ 
and substrate are highlighted. 
 
  BsIDH is assigned to the GFOR/IDH/MocA family of homologous 
dehydrogenases (63) and its active site residues Asp172 and H176 were predicted based 
on the sequence alignment analysis (61), homology model building and manual docking 
studies (60). The structures for apo-enzyme, holo-enzyme and apo-K97V mutant and the 
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ternary complexes with myo-inositol and scyllo-inosose were determined (63, 64). These 
structural studies have revealed that, K97 is also involved in a proton transfer to D172 
through a water molecule during catalysis. Each monomer shows two structurally distinct 
domains (Figure 1.4). The N-terminal domain spans up to 124 amino acid residues and it 
forms a characteristic dinucleotide binding Rossmann fold with a centrally arranged 
parallel β-sheet surrounded by α-helices. The rest of the protein sequence (125-337 
residues) forms the C-terminal domain. It consists of 6 α-helices, an antiparallel oriented 
6-stranded β-sheets and an antiparallel oriented two-stranded short β-sheet which extends 
out from the core monomer. This extended structure of each monomer is held together to 
form a tetramer. The coenzyme (NAD
+
) binds to the N-terminal domain with its 
nicotinamide ring pointing towards the active site present at the interface of the two 
domains, where the substrate binds.  
 
 
1.5 IDH-related enzymes 
 Genome sequencing and multiple sequence alignment analysis of many bacterial 
DNA have demonstrated the presence of multiple genes encoding for IDH-related 
enzymes. For example, Lactobacillus casei BL23 (Lc_iolG1 and Lc_iolG2) (27), 
Salmonella enterica serovar Typhimurium (St_iolG1 and St_iolG2) (65), 
Corynebacterium glutamicum (Cg_iolG1 to Cg_iolG3) (26), and  Lactobacillus 
plantarum WCFS1 (Lp_iolG1 to Lp_iolG4) (52).  
 Multiple sequence alignment of these IDH-related enzymes with the sequence and 
structure of BsIDH has led to the identification of six different consensus sequence 
motifs of which motifs I and II are involved in NAD
+
/NADH binding while the other 
four motifs define the binding pocket of the active site for these enzymes (63). Based on 
these findings, the putative IDH-related enzymes were classified into four subgroups. A 
multiple sequence alignment of IDH-related enzymes from L. plantarum WCFS1 and L. 
casei BL23 with BsIDH is shown in Figure 1.5.  
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Figure 1.5: Multiple sequence alignment IDH-related enzymes from L. plantarum WCFS1, L. casei 
BL23 and BsIDH. The consensus sequence motifs are highlighted in colors, the active site residues (K97, 
D172 and H176) are indicated with red star.  The image is generated using ClustalW2 and ESPript V2.2 
softwares based on the information reported in Biochemical Journal (2010), 432, 237-247. 
 
 
 BsIDH, StIDH and LpIDH2 are included in subgroup I, in which the amino acid 
residues involved in substrate binding are highly conserved indicating that they are 
probably myo-inositol dehydrogenases. It was reported that the protein sequence of 
LcIDH1 has high percentage of sequence identity with BsIDH and considered as the 
actual IDH for L. casei BL23 (27). The enzymes that showed high percentage sequence 
identity with LpIDH1 are included in subgroup II and LcIDH2 has 46% sequence identity 
with LpIDH1.  
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 Subgroup III includes TmIDH, CgIDH, LpIDH3 and IDHA from Rhizobium and 
Brucella species, and MocA from various species of Brucella. These enzymes have a 
proline-rich loop between β-strand 7 and α-helix 7 in their substrate binding pocket, 
which forms a flexible left-handed  poly-proline helix (PP_II helix) (66). It was proposed 
that this loop may make the adjacent α-helix to close the active site after the substrate or 
coenzyme binding (67). Also found was that these members have high sequence identity 
among themselves than compared to other group members. LpIDH4 is included in 
subgroup IV. Although, the structure is not available for this subgroup, the consensus 
sequence motifs I, II, III, V and VI of these members show similarity to subgroup III, but 
only motif IV is different. Recent studies by Zhang et al have identified iol operons from 
several species of Lactobacillus by comparing the genome sequences with B. subtilis and 
reported that most of the L. casei species show similar kind of iol operons (68).   
 
1.5.1 Studies on LpIDH1 
Before I started this research project, the protein structure for LpIDH1 was 
known, (PDB code: 3CEA). The clone was obtained from the Joint Center for Structural 
Genomics. In our lab LpIDH1 was first expressed and purified by Hongyan Zheng and its 
functional characterization had been studied to a little extent by Natasha Vetter and Grey 
Wilkinson, undergraduate students from this lab. It was established that LpIDH1 reacts 
with scyllo-inosose. The product of this reaction shows a UV absorption peak at 304 nm. 
Different buffers with varying pH conditions were tested for LpIDH1 activity and the 
kinetic assays were performed in 100 mM Bis-Tris buffers pH 6.5 at 25
o
C.  In 1979 
Angyal et al has reported that in basic solutions scyllo-inosose isomerizes into enediols 
that show UV absorption peak at 304 nm (69).  This suggested that buffers with basic pH 
are not suitable for measuring LpIDH1 activity. The effect of NAD
+
 and NADH in this 
reaction seems to be little or even negligible. Later, Ryan Stubbins, another 
undergraduate student from Dr. David A. R. Sanders lab has determined the crystal 
structures for wild type and the mutants and found that the NAD
+ 
was intrinsically bound 
to the purified LpIDH1. However, the product of this reaction was not identified and the 
role of NAD
+
 bound to this enzyme is not known. Figure 1.6 shows the structure of 
LpIDH1 with NAD
+
. 
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Figure 1.6: Structure of LpIDH1 (PDB code: 3CEA). The N-terminal domain with bound NAD
+
 is 
indicated in cyan and the C-terminal domain is shown in brown.  
 
1.6  Mechanisms of two substrate reaction  
The enzyme catalyzed reactions involving two substrates and two products are 
called as Bi-Bi reactions (70). An example of a Bi-Bi reaction is shown in Scheme 1.2. 
 
 
Scheme 1.2: Bi-Bi reaction 
 
 Where, [A] and [BX] are substrates and [AX] and [B] are products respectively. 
On the basis of the binding order of the substrates and the releasing order of products, the 
Bi-Bi reactions are identified to follow three types of mechanisms and named as random 
ordered, compulsory or sequentially  ordered, and Ping-Pong mechanisms. In random 
ordered mechanism, either substrate A or BX will bind first to the enzyme before 
catalysis, after catalysis either product AX or B will release first, as shown in Scheme 
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1.3. The binding of first substrate is independent of the binding of the second substrate. 
The conversion of glucose to glucose-6-phosphate by hexokinase, using ATP is an 
example of random ordered mechanism.  
 
Scheme 1.3: Random ordered mechanism for a Bi-Bi reaction. 
 
In compulsory ordered or sequentially ordered mechanism, substrate A will bind 
first followed by the second substrate BX to the binary complex [E‒A] and forms a 
ternary complex [E-A-BX] before catalysis, as shown in Scheme 1.4. After catalysis, the 
ternary complex containing products, [E-AX-B] will breaks down to release the product 
B first followed by AX. Dehydrogenase enzymes are reported to follow this type of 
mechanism. As described in section 1.4, the reaction catalyzed by BsIDH is a Bi-Bi 
reaction and it follows a sequentially ordered mechanism during catalysis (56) (58). Here 
the substrate NAD
+
 binds first to BsIDH followed by myo-inositol. After catalysis, the 
product scyllo-inosose is released first followed by NADH. 
Scheme 1.4: Compulsory ordered mechanism for a Bi-Bi reaction 
 
In Ping-Pong mechanism, the enzyme converts the first substrate BX into the 
product B. During this conversion, an atom or a group of BX remains attached to the 
enzyme, shown as [EX] in the Scheme 1.5. Then the second substrate A binds to [EX] 
and gets converted into AX. In this way an atom or a group from BX is transferred to A. 
Aminotransferase is an example of a Ping-Pong mechanism.  
Scheme 1.5: Ping-Pong mechanism for a Bi-Bi-reaction. 
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These mechanisms can be distinguished by double reciprocal plot of the kinetic 
data. That is, the initial velocity data is plotted as 1/[initial velocity] versus 1/[substrate] 
and if the plot displays a set of lines intersecting towards the left of the y-axis, it indicates 
that the reaction follows an ordered (either random or sequential) mechanism and if the 
plot displays a set of parallel lines, it indicates that the reaction follows a Ping-Pong 
mechanism in the Bi-Bi-reactions. Two inhibition methods such as dead end inhibition 
and product inhibition can further distinguish the random ordered and the compulsory 
ordered mechanism.  
1.7  Kinetic isotopic effect (KIE)  
Kinetic isotopic effect (KIE) can be explained as the change in the rate of a 
reaction when an atom of the substrate is substituted by its isotope and used in the same 
reaction. Isotopic substitution affects only the mass dependant properties such as 
vibrational frequency of the atoms (71). Mathematically, the theoretical and the 
experimental KIE can be represented as the ratio of kH/kD, where kH is the rate constant of 
the reaction when performed with normal substrate and kD is the rate constant of the 
reaction when performed with the isotope substituted substrate (72). The magnitude of 
the KIE value depends on the relative mass difference between the atom and its isotope 
and in most of the KIE experiments hydrogen is substituted with deuterium or tritium. 
KIE is classified into primary KIE and secondary KIE based on the position of the 
isotope relative to the site of bond making or bond breaking in the rate determining step 
of a reaction mechanism (73). When the isotopic substitution is at the site of bond making 
or breaking in the rate determining step, it is called as the primary KIE and when the 
isotopic substitution is adjacent to the site of bond making or breaking in the rate 
determining step, it is called as the secondary KIE. The secondary KIE is always lesser 
than the primary KIE, and the maximum theoretical values for the primary deuterium 
KIE is 6.9, the secondary deuterium KIE is 1.2, whereas the primary tritium KIE is 18 
(72). The concept of kinetic isotopic effect can be applied to enzyme catalyzed reactions 
to determine the rate determining step of the reaction mechanism. The KIE of an enzyme 
catalyzed reaction can be represented as 
X
Vmax, 
X
(Vmax/Km), or  
X
(kcat/Km), where the 
superscript X is the isotopic substitution.  
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2.      RESEARCH OBJECTIVES 
Although IDH-related enzymes from different bacteria have been identified and 
their functions were hypothesized, it is not clear whether these predicted enzymes have 
similar functions, share the same structural features or display different specificities 
towards inositol isomers or other structurally related compounds. Therefore, this research 
project was aimed at the investigation of IDH-related enzymes from Lactobacillus 
plantarum WCFS1 and Lactobacillus casei BL23. BsIDH was chosen as a comparative 
model in this study because it has been characterized structurally and functionally to a 
great detail in our lab collaborating with Dr. David A. R. Sanders laboratory. Here are the 
objectives of this research:  
 
1. clone all genes that encode inositol dehydrogenase  from L. plantarum WCFS1 
(Lp_iolG1 to Lp_iolG4) and L. casei BL23 (Lc_iolG1 and Lc_iolG2); 
2. express and purify IDH-related enzymes (LpIDH1 to LpIDH4, and LcIDH1 & 
LcIDH2) in their active form; 
3. observe dehydrogenase activity with myo-inositol and/or other related compounds; 
4. study the pH-rate profiles, determine the true kinetic constants and identify the 
substrate spectrum for all enzymes that are showing dehydrogenase activity; 
5. compare the pH-rate profiles, the true kinetic constants and the substrate spectrum of 
the active enzyme/s with BsIDH; 
6. if possible, rationalize the activity differences between these enzymes by comparing 
their sequences and/or structures to each other and to BsIDH. 
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3.  MATERIALS AND METHODS 
3.1  Materials and instrumentation 
Lactobacillus plantarum WCFS1 was purchased from the American Type Culture 
Collection (ATCC # BAA-793) and Lactobacillus casei BL23 was purchased from the 
Spanish Type Culture Collection (CECT # 5275). Gluconobacter oxydans was purchased 
from American Type Culture Collection (ATCC # 621H). Escherichia coli XL1 Blue and 
E.coli BL21 Gold (DE3) competent cells were purchased from Novagen
®
, EMD 
Biosciences, ON, Canada. MRS broth media was purchased from Sigma-Aldrich, (ON, 
Canada) and other culture media ingredients such as Yeast Extract, Peptone, Tryptone 
and Agar were purchased from Becton, Dickinson and Company, (BD) USA and/or EMD 
Biosciences, ON, Canada. DNA primers used in PCR were purchased from Integrated 
DNA Technologies (IDT), IW, USA. PfuUltra
®
 HiFi DNA polymerase (Stratagene, 
Agilent Technologies Ltd) and/or KAPA HiFi DNA polymerase (KAPA Biosystems, 
MA, USA.) were used for gene amplification reactions. QIAprep Spin Miniprep Kit, 
QIAprep PCR Purification Kit and QIAprep Gel Extraction Kit and the vector pQE-80L 
were purchased from QIAGEN Inc, ON, Canada.  
Restriction enzymes, T4 DNA Ligase and other reagents used in gene cloning 
experiments were purchased from New England Biolabs (NEB), MA, USA. A HiTrap-
IMAC FF 1mL columns and a Chelating Sepharose™ Fast Flow resin were purchased 
from GE Healthcare, QC, Canada. A Spectra/Por
®
 # 7 (25 kDa MWCO) protein dialysis 
membrane was purchased from Spectrum Laboratories, CA, USA. Chemical compounds 
like scyllo-inosose, 2-
1
H-myo-inositol and 2-
2
H-myo-inositol used for kinetic isotopic 
effect (KIE) experiments were prepared as described previously in Hongyan Zheng’s 
PhD thesis (61). All other materials and reagents used in this research were purchased 
from Sigma-Aldrich (ON, Canada), VWR (ON, Canada), Alfa Aesar (MA, USA) or TCI 
America (OR, USA).  
Bacillus subtilis iolG (Bs_iolG) gene was previously cloned into NdeI and BamHI 
sites in the multiple cloning sites (MCS) of pET-28b vector (EMD Biosciences) by Mike 
Laliberte, a summer student form this laboratory. E. coli host cell containing pET-28b-
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Bs_iolG plasmid was used for the expression of BsIDH. Bacterial culture media was 
sterilized using either a table top sterilizer (VWR) or a Castle
®
 233LS vacuum steam 
sterilizer (GETINGE Canada Ltd., ON Canada). Distilled deionized water (ddH2O) was 
obtained from a Barnstead NANOpure
®
 DIamond
™
 Life Science (UV/UF) ultrapure 
water system. A Beckman Coulter microfuge-18R table-top centrifuge was used during 
genomic DNA and plasmid DNA purification processes. A Mastercycler
®
 Gradient 
(Eppendorf) is a PCR device used to amplify inositol dehydrogenase related genes by the 
polymerase chain reaction (PCR) method. DNA concentrations were measured using a 
NanoDrop™ 1000 Spectrophotometer (Thermo Scientific). DNA analyses of PCR 
amplified DNA fragments, plasmid DNA samples and all other DNA samples during 
gene cloning experiments were performed using a Sub-cell
®
 GT agarose gel 
electrophoresis unit (Bio-Rad).  
Temperature controlled orbital shaker incubators were used for bacterial cell 
culturing and protein expression. A Virsonic 600 ultrasonic cell distrupter (VirTis 
Company) was used for cell lysis during protein isolation. A Beckman Coulter Avanti J-E 
high speed centrifuge was used during, cell harvesting, protein separation from cell 
debris, and protein concentrations. A HiTrap-IMAC FF 1 mL column and an XK 16 
column (GE Healthcare) packed with Chelating Sepharose™ Fast Flow resin was used 
for protein purification. A Mini-PROTEAN 3 electrophoresis unit (Bio-Rad) was used to 
perform SDS-polyacrylamide gel electrophoresis. Protein concentration measurements 
and enzyme kinetic assays were performed using a Beckman DU640 UV-VIS 
spectrophotometer connected to a temperature controlled circulating-water bath. DNA 
sequencing was performed at DNA Technologies Unit, National Research Council, Plant 
Biotechnology Institute (NRC-PBI), Saskatoon, SK, Canada. 
 
3.2  Preparation of substrates 
3.2.1 Biotransformation of myo-inositol to scyllo-inosose (74) 
   A loop full of Gluconobacter oxydans from the glycerol stock was transferred into 
a test tube containing 10 mL revitalizing media (1.0 g D-sorbitol, 0.05 g yeast extract) 
and incubated by shaking aerobically at 200 rpm and 30 
o
C overnight. A flask containing 
300 mL of sterile revitalizing myo-inositol media (0.3 g D-sorbitol, 1.5 g yeast extract, 
and 8.25 g myo-inositol was inoculated with 2.5 mL of overnight culture and incubated at 
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the same conditions for 4 days (96 h). After 96 h incubation, the cells were harvested by 
centrifugation at 3,500 ×g for 30 min and the supernatant was collected into a clean 500 
mL round bottomed flask. The supernatant was reduced to half of its original volume by 
evaporation at 40
o
C. An equal volume of ice-cold MeOH was added to the resultant 
supernatant and kept at -20
o
C for 2 more days. The precipitate was filtered, washed with 
10 mL fresh ice-cold MeOH and air dried to afford scyllo-inosose as a white powder. The 
overall yield obtained was 4.65 g, (56%). m.p: 190 - 192 
o
C, Lit (74) m.p: 188 - 192 
o
C, 
1H-NMR (D2O): δ 4.36 (2H, d, J = 10 Hz), 3.77 (1H, t, J = 9.5 Hz), 3.5-3.2 (2H, m) ppm.  
 
3.2.2 Preparation of 2-2H-myo-inositol and myo-inositol 
   Chemical compounds such as 2-
2
H-myo-inositol and myo-inositol were prepared 
according to the procedure described in Hongyan Zheng’s PhD thesis (61). The overall 
yield for 2-
2
H-myo-inositol and myo-inositol was 28% and 33% respectively. The 
1
H 
NMR for 2-
2
H-myo-inositol (D2O): δ 3.58 (2H, t, J = 9.8 Hz,), 3.49 (2H, d, J = 10 Hz), 
3.25 (1H, t, J = 9.3), and myo-inositol (D2O): δ 4.01 (1H, t, J = 2.8 Hz), 3.58 (2H, t, J = 
9.7 Hz), 3.49 (2H, dd, J = 2.9 Hz and 10 Hz), 3.23 (1H, t, J = 9.4 Hz) ppm. 
 
3.3  Microbiology methods 
3.3.1  Preparation of culture media 
  L. plantarum WCFS1 and L. casei BL23 strains were cultured in De Man, Ragosa 
and Sharpe (MRS) media. E. coli XL1 Blue or BL21 host cells containing a recombinant 
plasmid were regularly performed in a Luria-Bertani (LB) media. Terrific Broth (TB) 
was used for routine gene expression experiments. MRS and LB agar plates were 
prepared by adding 1.5% (w/v) agar to the liquid media (also called as broth) before 
sterilization.  After sterilization, the media was cooled to about 45-50 
o
C; antibiotics such 
as ampicillin (50 µg/mL) or kanamycin (50 µg/mL) were added as required and then, the 
media was poured into petri plates and allowed them to solidify under aseptic conditions. 
Finally, the sterile media (broth and agar plates) was stored at 4 
o
C for future use. The 
compositions for all types of media used in this research were indicated in Appendix-A. 
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3.3.2  Preparation of the glycerol stocks of bacterial strains 
  Lyophilized cell pellets of L. plantarum WCFS1 and L. casei BL23 were 
resuspended separately in 0.5 mL of MRS broth by following the supplier’s instructions. 
A loop full of each suspension was streaked separately on MRS agar and the plates were 
incubated at 37 
o
C overnight. Remaining samples were transferred into separate test tubes 
containing 5 mL of fresh and sterile MRS broth and the tubes were incubated by shaking 
aerobically at 250 rpm and 37 
o
C overnight. The agar plates having colonies were 
wrapped with the parafilm and stored at 4 
o
C for future use. The cells were harvested 
from the 5 mL overnight culture by centrifugation at 18,000 ×g for 1 min and the cell 
pellets was resuspended in 1 mL of 80% sterile glycerol. The glycerol stocks were 
preserved at -80 
o
C for future use. 
 
3.3.3  Preparation of competent cells 
  E. coli competent cells were prepared according to the method adopted from 
Hongyan Zheng’s PhD thesis (61). E. coli XL1 Blue and BL21 cells were initially grown 
on LB agar plate at 37 
o
C overnight. A single colony of each type was transferred into 
separate test tubes containing 5 mL of sterile LB broth and tetracycline (50 µg/mL) and 
the tubes were incubated by shaking aerobically at 250 rpm and 37 
o
C overnight.  
  The overnight culture (1 mL each) was transferred separately into 500 mL flasks 
containing 150 mL of fresh LB broth and 50 µg/mL of tetracycline and incubated at the 
same conditions as above, until the cell growth reached ~ 0.4 AU, measured at A600. The 
growth of the cells was not allowed to exceed 0.4 AU. At this point, the cultures were 
transferred into pre chilled 50 mL falcon tubes and incubated on ice for 10 min. 
Following the incubation, the cultures were centrifuged at 1,500 ×g for 20 min at 4 
o
C 
and the supernatant was discarded. The tubes were held upside-down for several minutes 
to remove the supernatant completely. Then cell pellets were resuspended in 20 mL of 
sterile ice-cold transformation buffer (25 mM Tris-Cl pH 7.5, 20 mM CaCl2.2H2O) and 
incubated on ice for 30 min. After incubation, the samples were centrifuged again at 
1,500 ×g for 20 min at 4 
o
C, the supernatant was discarded and cell pellets were 
resuspended in 5 mL of sterile ice-cold transformation buffer. To this cell suspension, 5 
mL of 80% sterile glycerol was added and mixed by vortex. Finally, the glycerol stocks 
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of the competent cells were prepared into 100 µL aliquots and stored at -80 
o
C for future 
use. 
 
3.4   Molecular biology methods 
3.4.1  Isolation of genomic DNA and plasmid DNA 
 L. plantarum WCFS1:  A single colony of L. plantarum WCFS1 was taken from 
an agar plate, transferred into a test tube containing 5 mL MRS broth and cultured by 
shaking aerobically at 250 rpm and 37 
o
C overnight. Cells were harvested from the 
overnight culture by centrifugation at 18,000 ×g for 1 min at room temperature. The 
genomic DNA was isolated by using an UltraClean
®
 Microbial DNA Isolation Kit, MO 
BIO Laboratories, Inc., CA, USA. This kit was generously provided by Vanessa Pittet 
and Professor Dr. Barry Ziola from Department of Microbiology and Immunology, 
University of Saskatchewan along with the technical assistance. Hence, the genomic 
DNA of the L. plantarum WCFS1 was prepared, according to the manufacturer’s 
protocol. The DNA sample was immediately used for further experiments or stored at      
-20 
o
C for future use. All the steps in the above protocol were performed at room 
temperature.  
L. casei BL23:  A test tube containing 5 mL of sterile MRS broth was inoculated 
with a loop full of L. casei BL23 taken from the glycerol stock and cultured by shaking 
aerobically at 250 rpm and 37 
o
C overnight. Genomic DNA was isolated using a phenol: 
chloroform: isoamyl alcohol (25:24:1) protocol, adopted from Dr. Bonnie Chaban, 
research associate in Dr. Janet Hill’s laboratory, Department of Veterinary Microbiology, 
Western College of Veterinary Medicine, University of  Saskatchewan.  
According to this protocol, L. casei BL23 cells were pelleted from a 5 mL 
overnight culture, by centrifugation at 18,000 ×g for 1 min and resuspended in a 1.5 mL 
Eppendorf tube using  630 µL of TE buffer (100 mM Tris-HCl pH 8.0, 10 mM EDTA). 
To this suspension, 70 µL of 10% SDS (w/v) was added, mixed by inverting 2-3 times 
and incubated at 37 
o
C for 10 min. Following the incubation, 17.5 µL of lysozyme (100 
mg/mL) and 4 µL of RNase (10 mg/mL) were added, mixed by inverting 2-3 times and 
incubated again at 37 
o
C for 30 min. To this sample mixture, 8 µL of Proteinase K (20 
mg/mL) was added, mixed by inverting 2-3 times and then incubated again at 50-55 
o
C 
for 45 min. After incubation, the crude sample containing genomic DNA was extracted 
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with 700 µL of phenol: chloroform: isoamyl alcohol (25:24:1). The resultant sample was 
centrifuged at 18,000 ×g for 3 min, using a table top centrifuge. The top aqueous layer 
was carefully transferred into a fresh Eppendorf tube and extracted again with 350 µL of 
chloroform: isoamyl alcohol (24:1). Again the top aqueous layer was collected into a 
fresh Eppendorf tube. To this aqueous sample, 1/10
th
 volume of 5 M NaCl and 2 volumes 
of  ice cold 95% ethanol were added and mixed by inverting several times. The 
Eppendorf tube was incubated at -20 
o
C of 30 min, during which time the genomic DNA 
gets precipitated out. Following the incubation, the sample was centrifuged at 18,000 ×g 
and 4 
o
C for 10 min to separate the supernatant. Then, 100 µL of 70% ethanol was added 
and the tube was gently inverted 2-3 times and centrifuged at 18,000 ×g for 3 min. Once 
the supernatant was removed, the Eppendorf tube was completely air dried for about 5-10 
min, by keeping tube in inverted position. Finally, the DNA pellet was resuspended in 50 
µL of sterile ddH2O and the concentration was measured by using a NanoDrop™ 1000 
Spectrophotometer. 
Plasmid DNA: E. coli host cells harboring either pQE-80L or recombinant 
constructs (pQE-80L-IDH-related gene) were cultured by shaking aerobically at 250 rpm 
and 37 
o
C overnight. Cells were harvested from the overnight culture by centrifugation at 
18,000 ×g for 1 min at room temperature and the plasmid DNA was isolated using a 
QIAprep Spin Miniprep Kit, according to the manufacturer’s protocol, but with a change 
that the plasmid DNA was eluted with 30 µL sterile ddH2O.   
 
3.4.2  Primer designing 
To amplify the IDH-related genes from L. plantarum WCFS1 and L. casei BL23 
genomic DNA, a forward primer and a reverse primer specific to each gene were 
designed, based on their sequences available from online database, Kyoto Encyclopedia 
of Genes and Genomes (KEGG) (75). The DNA sequence for each gene was obtained by 
a specific entry name. Inositol dehydrogenase-related genes from L. plantarum WCFS1, 
L. casei BL23 and B. subtilis are indicated with their KEGG database entry names in 
Table 3.1.   
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Table 3.1: IDH-related genes and their identification names in KEGG database 
Bacteria genes KEGG entry name 
Lactobacillus plantarum WCFS1  
Lp_iolG1 lp_3605 
Lp_iolG2 lp_3606 
Lp_iolG3 lp_3608 
Lp_iolG4 lp_3612 
Lactobacillus casei BL23  
Lc_iolG1 LCABL_02210 
Lc_iolG2 LCABL_02220 
 
Restriction sites compatible with the MCS of the pQE-80L vector, were inserted 
in the primer sequences to flank the ends of each gene after PCR amplification. An online 
OligoAnalyzer tool from Integrated DNA technologies was used to optimize parameters 
such as length, melting temperature (Tm), %GC, and formation of dimer and hairpin etc. 
All the primers used for cloning IDH-related genes are provided in Table 3.2.  
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3.4.3  Polymerase chain reaction (PCR) 
3.4.3.1 Amplification of IDH-related genes form L. plantarum WCFS1 
Lp_iolG1 to Lp_iolG4 genes were amplified using their respective forward and 
reverse primers. Reactions were prepared in 12 × 200 µL PCR tubes to a final volume of 
50 µL, as mentioned in Table 3.3. All four gene amplification reactions were carried out 
in a Mastercycler
TM
 Gradient using the program mentioned in Table 3.4.  
 
Table 3.3: PCR mixture for the amplification of Lp_iolG1 to Lp_iolG4 genes. 
Polymerase chain reaction mixture  
 Sterile ddH20 40.5 µL 
10X PfuUltra
®
 Buffer* 5 µL 
 
10 mM dNTP mix 1 µL 
 
10 µM forward primer 1 µL 
 
10 µM reverse primer 1 µL 
 
Genomic DNA template (~0.8 ng/µL) 1 µL 
 
PfuUltra
®
 HiFi DNA polymerase 0.5 µL 
Total volume 50 µL 
* (200 mM Tris–HCl, pH 8.8, 100 mM KCl, 100 mM (NH4)2SO4, 
20 mM MgSO4, 1% TritonX-100, and 1.0 mg/mL BSA) 
 
 
 
 
Table 3.4: PCR program for the amplification of Lp_iolG1 to Lp_iolG4 genes. 
PCR Program  
 
1.    Initial denaturation     T = 95 
o
C 5 min 
 
2.    Denaturation T = 98 
o
C 20 sec 
 
3.    Annealing T = 55 
o
C 15 sec 
 
4.    Extension T = 72 
o
C  35 sec 
Go to step-2 and repeat for 39 cycles 
 
5.    Final extension T = 72 
o
C  5 min 
Hold at 4 
o
C or end program 
 
3.4.3.2 Amplification of IDH-related genes from  L. casei BL23 
 Lc_iolG1 & Lc_iolG2 genes were amplified using their respective forward and 
reverse primers Reactions were prepared in 12 × 200 µL PCR tubes to a final volume of 
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25 µL, as mentioned in Table 3.5. The two genes were amplified by using a gradient 
annealing temperature program, in a Mastercycler
TM
 Gradient, as mentioned in Table 
3.6. 
 
Table 3.5: PCR mixture for the amplification of Lc_iolG1 and Lc_iolG2 genes. 
Polymerase chain reaction mixture  
 
Sterile ddH20 
36 µL 
 
5X KAPA High Fidelity Buffer 10 µL 
 
10 mM dNTP mix 1 µL 
 
10 µM forward primer 0.75 µL 
 
10 µM reverse primer 0.75 µL 
 
Genomic DNA template (~7.6 ng/µL) 1 µL 
 
KAPA HiFi DNA polymerase 0.5 µL 
Total volume 50 µL 
 
 
Table 3.6: PCR program for the amplification of Lc_iolG1 and Lc_iolG2 genes 
PCR Program  
 
1.    Initial denaturation T = 95 
o
C 5 min 
 
2.    Denaturation T = 98 
o
C 20 sec 
 
3.    Gradient annealing T = 50-60 
o
C 15 sec 
 
4.    Extension T = 72 
o
C  35 sec 
Go to step-2 and repeat for 34 cycles 
 
5.    Final extension T = 72 
o
C  5 min 
Hold at 4 
o
C or end program 
 
After PCR, 2-3 µL of the reaction mixture was analyzed by 1% agarose gel 
electrophoresis and the rest of the samples were purified by using a QIAquick PCR 
Purification Kit, according to the manufacturer’s protocol, but with a change that final 
pure DNA was eluted with 30 µL sterile ddH2O. 
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3.4.4 Restriction digestion 
All the PCR products (Lp_IolG1 to Lp_iolG4 and Lc_iolG1 & Lc_iolG2 genes) 
were digested separately with their respective restriction enzymes. Similarly, pQE-80L 
was also digested with the corresponding enzymes to generate compatible cohesive ends. 
The digestion reaction mixtures were prepared on ice. A total volume of 50 µL in 200 µL 
PCR tubes, containing 1X concentration of an appropriate buffer, ~200-400 ng/µL of 
DNA sample, and 20-50 units of restriction enzymes. Bovine Serum Albumin (1 µL of 
10 mg/mL concentration) was added to the reaction mixture as required. The reactions 
were carried out in a Mastercycler
TM
 Gradient with a program set at 37 
o
C for 2 h. The 
combination of restriction enzymes used to digest the PCR products and the vector is 
indicated in Table 3.7.  
 
Table 3.7: Combination of enzymes used in restriction digestion process 
PCR product and the native vector Combination of the restriction enzymes  
Lp_iolG1 and pQE-80L  BamHI and PstI 
Lp_iolG2 and pQE-80L  BamHI and SphI 
Lp_iolG3 and pQE-80L  BamHI and XmaI 
Lp_iolG4 and pQE-80L  SphI and XmaI 
Lc_iolG1 and  pQE-80L BamHI and XmaI 
Lc_iolG2 and  pQE-80L BamHI and PstI 
 
After restriction digestion, the DNA samples were purified from 0.7% agarose gel by 
using a QIAquick Gel Extraction Kit, following the manufacturer’s protocol, but with a 
change that final pure DNA was eluted with 30 µL sterile ddH2O.  
 
3.4.5 DNA ligation 
The purified gene inserts (Lp_iolG1 to Lp_iolG4, Lc_IolG1 & Lc_iolG2) with 
their cohesive ends were ligated into the MCS of pQE-80L that was digested with 
corresponding enzymes, as mentioned in section 3.4.4. The ligation reaction mixture was 
prepared in a typical volume of 10 µL containing 1.0 µL of 10X T4 Ligation buffer, 3:1 
molar ratio of insert to plasmid, 1.0 µL of T4 DNA Ligase enzyme. A negative control 
reaction was prepared simultaneously by adding everything to the reaction mixture 
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except the insert. All the ligation reaction mixtures were prepared on ice, mixed by taping 
and the reaction was carried out at room temperature for about 1 h. After the ligation 
reaction, the sample was transformed into E. coli competent cells. 
 
3.4.6 Transformation 
  Frozen stocks of competent cells (E. coli XL1-Blue and/or BL21-Gold) were 
thawed on ice before starting the transformation. The reaction mixture after ligation 
reaction was added and incubated on ice for 30 min. Following the incubation, the cells 
were subjected to heat-shock for 1 min in a water bath maintained at 42 
o
C. Immediately 
after heat-shock, the sample was kept on ice for 2 min and then transferred into a sterile 
1.5 mL Eppendorf tubes containing 900 µL LB media. The tubes were incubated by 
shaking at 250 rpm and 37 
o
C for 1 h. After incubation, the sample was plated onto LB 
agar containing 50 µg/mL of ampicillin, and incubated at 37 
o
C overnight. 
 
3.4.7 Screening and selection of viable clones 
To confirm successful ligation, 6-8 colonies for each clone were selected for 
restriction analysis. The selected colonies were cultured in test tubes, containing 5 mL 
LB broth and 50 µg/mL of ampicillin, by shaking aerobically at 250 rpm and 37 
o
C 
overnight. A loop full of each culture was streaked on LB agar containing 50 µg/mL of 
ampicillin and the plates were incubated at 37 
o
C overnight and kept for future use. The 
remaining culture was harvested by centrifugation at 18,000 ×g for 1 min and the 
recombinant constructs were isolated using a QIAprep Spin Miniprep Kit, according to 
the manufacturer’s protocol. 
Restriction enzymes that could cut the plasmid DNA through the inserted gene 
were chosen. After restriction digestion the DNA fragments of different size were 
analyzed by 1% agarose gel electrophoresis. A virtual restriction analysis of all the 
recombinant constructs was performed using DNADynamo software and compared to the 
restriction digest results.  Clones with results matching to the expected virtual analysis 
were submitted for DNA sequencing. Finally, clones having the correct DNA sequence 
were made into stocks and stored at -80 
o
C in 80% sterile glycerol.  
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3.5   Gene expression 
   E. coli host cells harboring the recombinant vector (for example: pQE80L-
Lp_iolG1) were taken from their frozen stocks and streaked onto LB agar containing 50 
µg/mL concentration of ampicillin and incubated at 37 
o
C overnight. Kanamycin at 50 
µg/mL concentration was used during the expression of pET-28b-Bs_iolG.  A test tube 
containing 5 mL of sterile TB was inoculated with a single colony picked from the agar 
plate and incubated by shaking aerobically at 250 rpm and 37 
o
C overnight. A 1 mL of 
overnight culture was transferred into a 500 mL flask containing 100 mL of fresh TB and 
incubated by shaking aerobically at 250 rpm and 37 
o
C. Growth was monitored by 
measuring the turbidity of the culture spectrophotometrically at 600 nm (OD600) at 
regular time intervals. When the OD600 reached about 0.6-0.8 AU, isopropyl β-D-
thiogalactoside (IPTG) was added to a final concentration of 1 mM to induce 
overexpression of the gene. The culture was further incubated overnight at 15 
o
C and 250 
rpm. Finally, the cells were harvested by centrifugation at 3500 ×g for 30 min and the 
cell pellet was either immediately used for protein isolation and purification or stored at   
-80 
o
C for future use. 
 
3.6 Protein isolation and purification 
Fresh or frozen cell pellet was thawed on ice and resuspended in 5 mL of binding 
buffer (25 mM Tris-HCl pH 8.0, 0.5 M NaCl, 10 mM imidazole, and 10% glycerol), 
lysozyme and DNase were added in 1:1000 volume ratio, then cell lysis was performed 
using a Virsonic 600 ultrasonic cell disrupter with a program (5 s pulse on and 20 s pulse 
off) for 2 min. After sonication, the crude supernatant was separated from the cell debris 
by centrifugation at 15000 rpm and 4 
o
C for 30 min.  The crude protein extract was 
filtered through a 0.2 µm sterile syringe filter and loaded on to a 1 mL HiTrap-IMAC FF 
column which had been charged with 5 column volumes (CV) of charge buffer (50 mM 
NiSO4, pH 4.0) and equilibrated with 5 CV of binding buffer. Once the crude protein was 
loaded, the column was washed with 10 CV of wash buffer (25 mM Tris-HCl pH 8.0, 0.5 
M NaCl, 60 mM imidazole, and 10% glycerol). Then, protein bound to the column was 
eluted with either 10 CV of elution buffer (25 mM Tris-Cl pH 8.0, 0.5 M NaCl, 500 mM 
imidazole, and 10 % glycerol) or 10 CV of strip buffer (25 mM Tris-Cl pH 8.0, 500 mM 
NaCl, 100 mM EDTA and 10% glycerol).  
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For protein eluted with strip buffer, the column was charged and equilibrated 
again for the next use. The purity of the eluted fractions of protein was verified by 12% 
SDS-PAGE. The pure protein fractions were combined and concentrated using  a 30 kDa 
AMICON filter, by centrifuging at 3,500 ×g, dialyzed 2-3 time against dialysis buffer (25 
mM Tris-HCl pH 8.0, 40% (v/v) glycerol and 0.1 mM D-dithiothreitol (DTT)). Purified 
protein was separated into 100 µL aliquots, flash frozen in liquid nitrogen and 
immediately stored at -80 
o
C. For enzyme kinetic experiments, a single frozen aliquot of 
protein was thawed on ice and the concentration was adjusted to 1 mg/mL with fresh 
dialysis buffer.  
 
3.6.1 Purification of LpIDH2 from inclusion bodies 
 Fresh or frozen cell pellet from 100 mL of overnight culture was washed with 
ddH2O and resuspended in 5 mL denaturing buffer (100 mM NaH2PO4, 10 mM Tris-HCl 
pH 8.0, 8M Urea), then the sample was incubated for 30 min at room temperature. 
Supernatant was collected by centrifugation at 15000 rpm and 4 
o
C for 30 min. Denatured 
sample was filter using a 0.2 µM syringe filter and dialyzed against 500 mL refolding 
buffer (100 mM Tris-HCl pH 8.0, 1mM EDTA, 1mM PMSF, 400mM L-Arginine, 5% 
sucrose, 0.1mM DTT and 10% glycerol) with buffer change twice a day for 2 days. After 
dialysis the protein sample was purified by using a 1 mL HiTrap-IMAC FF column as 
mentioned in section 3.5. BsIDH was also purified by this method.  
 
3.6.2 Determination of protein concentration 
The concentration of protein samples was determined by A280 method, using a 
Beckman DU640 UV-VIS spectrophotometer. The absorbance was measured at two 
different dilutions of protein in 1 mL volume and the concentration for each dilution was 
calculated by using the Equation 3.1. The theoretical molar extinction coefficients (ε280) 
were obtained by submitting the protein sequences in the expasy protparam online tool. 
The average value of the two different concentrations obtained from the two dilutions 
was taken as the final concentration of the protein. 
             C = A280 (AU) / [ε280 (M-1cm-1) × L (cm)]                              Equation 3.1 
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3.7 Protein sequence analysis 
 Multiple sequence alignment of the primary protein sequences of IDH-related 
enzymes was performed with that of BsIDH using ClustalW2 multiple sequence 
alignment program (76, 77). The aligned sequences were compared to the structure of 
BsIDH and visualized by using ESPript V 2.2 software (78, 79).  
 
3.8 Enzyme kinetics 
3.8.1 Inositol dehydrogenase activity assay 
  The activity assays for the soluble IDH-related enzymes from L. plantarum 
WCFS1 and L. casei BL23, were performed in 1 mL cuvettes containing 100 mM Tris-
HCl pH 9.0, 50 mM myo-inositol, 2 mM NAD
+
 or NADP
+
 and 1 µL of enzyme (1 
mg/mL). According to the reaction mentioned in Scheme 1.1, formation of NADH or 
NADPH was monitored at λ = 340 nm (ε340 for NADH or NADPH is 6220 M
-1
cm
-1
) 
using a Beckman DU640 UV-VIS spectrophotometer at 25 
o
C. Similarly, other substrates 
such as scyllo-inositol, D-chiro-inositol, D-glucose, L-glucose (mixed anomers) and D-
xylose, L-xylose, D-galactose, D-mannose, D-sorbitol, D-mannitol and scyllo-inosose 
were also assayed.  
 
3.8.2 Initial velocity measurement assay 
 All the kinetic assays in this research were performed in a total reaction volume of 
1 mL, containing 100 mM concentration of an appropriate buffer at optimum pH. For 
determining the apparent kinetic constants NAD
+
 was kept constant at 2 mM while 
varying the other substrate. The reaction samples containing all the components were 
prepared except the enzyme and it was read as the blank sample. The reaction was 
initiated by adding the enzyme and the formation of NADH or NADPH was measured at 
340 nm, as mentioned in section 3.8.1, at 2 s intervals for a total time of 2 min. Data 
recorded by the spectrophotometer was converted into a Microsoft Excel file using 
DU600/700 File-Utility software (version 1.0), and then a plot of absorbance (A340) vs 
time was generated (Figure 3.1).  
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Figure 3.1: Absorbance versus time plot obtained from an IDH catalyzed reaction. Reaction 
conditions: 50 mM myo-inositol, 2 mM NAD
+ 
in 100 mM appropriate buffer at optimum pH and at 
25
o
C. 
 
 
 The data representing the linear portions of the absorbance curve was used to 
determine the slope (in AU s
-1
) and the initial velocity, (v0) was calculated from the slope 
by using the Equation 3.2 as shown below: 
 
 
 Hence, the initial rate of formation of NADH or NADPH in an IDH catalyzed 
reaction was calculated in nM s
-1
 for convenient representation in graphs. Each data 
points in this thesis represent the average value of at least two measurements taken from 
the spectrophotometer. 
 
3.8.3 Determination of optimum pH and the pH-rate profiles 
To determine the optimum pH and to establish the pH-rate profiles for the active 
enzymes (LcIDH1 and LcIDH2), including BsIDH, the initial rate of reactions containing 
a fixed concentration of myo-inositol (50 mM) and NAD
+
 (2 mM) in 100 mM of suitable 
buffer was measured at a series of pH values. A pH range from 9.0 to 10.5 with 0.1 unit 
difference was maintained by using the following buffers; CHES (N-cyclohexyl-2-
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aminoethanesulfonic acid) (Useful pH range: 8.6-10.0) and glycine-NaOH (Useful pH 
range: 8.8-10.6). The pH of the reaction mixture was measured before and after the 
reaction. The initial rate at each pH value was calculated as described in section 3.8.2, 
and the rate coefficients were plotted against the selected pH range of the reaction to 
generate pH-rate profiles. 
 
3.8.4 Determination of true kinetic constants ( Km , kcat and kcat/Km) 
  Kinetic assays for LcIDH1, LcIDH2 and BsIDH were performed in their 
respective buffer at optimal pH. To determine the true kinetic constants the assays were 
performed by varying the concentrations of myo-inositol or sugar at different fixed 
concentrations of NAD
+
 or vice-versa. Initial rates were determined as described in 
section 3.8.2, and the data was fitted to Equation 3.3 using Leonora software (80). 
 
v0  = 
Vmax [A][B] 
KiAKmB + KmB[A] + KmA[B] + [A][B] 
 
 where, v0 represents the initial velocity of the reaction, Vmax is the maximum 
velocity of the reaction when both substrates are at saturation concentrations, [A] is the 
concentration of the substrate (NAD
+
) that binds first to the enzyme, [B] is the 
concentration of the second substrate (myo-inositol or other related compounds), KmA and 
KmB are Michaelis constants for substrates A and B respectively, and KiA is the 
dissociation constant for the enzyme-NAD
+
 binary complex. Michaelis-Menten 
saturation curves (v0 vs [S]), Lineweaver-Burk Plots (also called double reciprocal plots) 
(1/ v0 vs 1/[S]) and the kinetic constants (KmA, KmB, and KiA) were obtained from Leonora. 
The other parameters such as turnover number (kcat) and specificity constant kcat/Km(A) and 
kcat/Km(B) were manually calculated using the total enzyme concentration used in the 
reaction mixture. 
 
3.8.5 Determination of apparent kinetic constants (Km
app
, kcat
app
 and kcat/Km
app
) 
 Apparent kinetic assays were performed by varying the concentrations of the 
myo-inositol and other related compounds at fixed saturation concentration of NAD
+
 (2 
mM). All the reactions were performed at least in duplicates to obtain the consistency in 
 Equation 3.3 
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data points. Initial rates were determined as described in section 3.8.2, and the data was 
fitted to Equation 3.4 using Leonora software.  
 
v0   =  
Vmax 
app 
[S] 
 Km 
app
 + [S]  
 
 where, v0  represents the initial velocity of the reaction, Vmax
app
 is the apparent 
maximum velocity of the reaction at saturation concentrations of the varied substrate, [S] 
is the concentration of the substrate (myo-inositol and other related compounds) and 
Km
app
 is apparent Michaelis constants for the varied substrate. Michaelis-Menten 
saturation curves (v0 vs [S]), double reciprocal plots (1/v0 vs 1/[S]) and the apparent 
kinetic constants (Km
app
) were obtained from Leonora. The other constants such as the 
apparent turnover number kcat
app
 and the apparent specificity constant (kcat/Km)
app
 were 
manually calculated using the total enzyme concentration used in the reaction mixture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equation 3.4 
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4.  RESULTS AND DISCUSSION 
4.1       Gene cloning  
4.1.1 Isolation of genomic DNA and plasmid DNA  
 In order to clone IDH-related genes from L. plantarum WCFS1 and L.casei BL23, 
their genomic DNA that serves as a template during the PCR was necessary. Hence, the 
genomic DNA of L. plantarum WCFS1 was isolated by using an UltraClean
®
 Microbial 
DNA Isolation Kit, as described in 3.4.1. In this method, the bacterial cells were lysed by 
the combination of heat, detergent, and mechanical forces against micro beads in a 
MicroBead tube provided in the kit. Following the cell lysis, the released DNA was 
allowed to bind to silica membrane in the spin filter column. The filter was washed, and 
finally, the pure genomic DNA was eluted with sterile ddH2O to obtain 8 µg of DNA 
from 2 mL bacterial culture.  
 The genomic DNA from L. casei BL23 was isolated by using a phenol: 
chloroform: isoamyl alcohol (25:24:1) protocol, as mentioned in section 3.4.1. The 
bacterial cells were lysed by heating the cell suspension in the presence of 10% SDS 
(w/v), RNase (10 mg/mL) and Proteinase-K (20 mg/mL). SDS disrupts the integrity of 
the bacterial cell wall and helps in cell lysis, RNase digests all types of RNA present in 
the crude sample and Proteinase-K is a serine protease that exhibits broad cleavage 
specificity and therefore digests all the proteins in the sample. The genomic DNA was 
then extracted using a phenol: chloroform: isoamyl alcohol (25:24:1) solution. The DNA 
dissolves in the top aqueous layer and gets separated from the organic-soluble 
components. Following the extraction, the DNA was further purified by precipitation 
with 5 M NaCl, ice cold 95% ethanol, and 70% ethanol. Finally, pure genomic DNA was 
dissolved in ddH2O to obtain 385 µg of DNA from 5 mL bacterial culture.  
 The pQE-80L plasmid (Figure 4.1) was selected for cloning all the genes because 
it carries different gene elements that are essential for its maintenance and efficient 
expression of highly stable N-terminal 6x-Histidine tagged recombinant proteins in the 
host cells. A lambda phage T5 promoter and lac operator elements are essential for 
regulating the protein expression (81). The E. coli RNA polymerase recognizes the T5 
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promoter sequence and initiates transcription. This region also has a strong ribosomal 
binding site (RBSII) which is required for efficient translation of mRNA. The pQE-80L is 
a cis-repressed plasmid, that is, it carries lacI
q
 gene element within its sequence which 
encodes lac repressor protein (82). The lac repressor protein binds to the lac operator and 
inhibits the transcription of the gene of interest.  
 The pQE-80L vectors can express proteins in any E. coli host cells. Protein 
overexpression can be achieved by the addition of isopropyl β-D-thiogalactoside (IPTG) 
into the growing culture. IPTG binds to the lac repressor protein and prevents it from 
binding to the lac operator region. This inactivation of lac repressor leads to successful 
transcription, and translation of the recombinant protein. The β-lactamase gene (bla) 
product confers resistance against ampicillin (83). Hence, E. coli host cells carrying this 
plasmid can survive in 50-100 mg/L concentration of ampicillin containing broth or agar 
plates. The other elements of this plasmid includes ColE1-Origin of replication(83), two 
strong transcription termination regions (t0 and T1) (84) and a chloramphenicol acetyl 
transferase (CAT) gene in between the transcription termination regions.  
 IDH-related genes from L. plantarum WCFS1 and L. casei BL23 strains were 
cloned into suitable cloning sites in the MCS region of pQE-80L overexpression plasmid. 
The pQE-80L plasmid and the recombinant constructs were isolated by using a QIAprep 
Spin Miniprep Kit to obtain about 12-15 µg of pure DNA at each time performed from a 
5 mL overnight culture. The DNA samples were diluted as required with sterile ddH2O 
and used in further experiments. 
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Figure 4.1: The DNA map of pQE-80L plasmid. (Gene elements are indicated in different colors, the 
arrow head indicates the direction of replication and transcription. The sequence encoding 6X-His Tag is 
towards the 5’ end of the multiple cloning sites (MCS) and the stop codons at 3’ end. The number adjacent 
to the restriction enzymes indicates their cut sites, XhoI site is the start of numbering. The image was 
generated using DNADynamo software. 
 
4.1.2 Amplification of IDH-related genes 
  Polymerase chain reaction (PCR) was performed in a series of 35-40 cycles with 
each cycle operating at three different temperature steps (85). When the temperature of 
the reaction was maintained at 95-98 
o
C, the double stranded genomic DNA (template) 
was denatured into two single stranded DNA. Following denaturation, the temperature 
was lowered to 50-55 
o
C, where both forward and reverse primers annealed to their 
complementary sequence in the single stranded DNA template. The temperature of the 
reaction was then changed to 72 
o
C, where the new DNA strands were synthesized by 
DNA polymerase from the 3’ end of the annealed primers, in the elongation process. 
After a specific number of repeated cycles, the gene of interest will increase in its copy 
number, which was analyzed by performing agarose gel electrophoresis.  
 IDH-related genes, (Lp_iolG1 to Lp_iolG4, and Lc_iolG1 and Lc_iolG2) from the 
L. plantarum WCFS1 and L. casei BL23 were amplified using their respective primers 
(Table 3.2). Initially, amplification trials were failed due to conditions such as the 
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presence of more DNA template in the reactions, primer annealing temperature and the 
amount of primers in the reactions. The PCR reactions were repeated by optimizing these 
conditions to achieve successful amplification of Lp_iolG1 to Lp_iolG4 genes. In case of 
Lc_iolG1 and Lc_iolG2, non-specific DNA amplifications were observed. The reactions 
were performed at gradient annealing temperature and with additives such as 5% DMSO 
and 5% formamide to minimize the non-specific DNA amplifications. These trials 
resulted in no amplification at all. Therefore, another trial was performed at gradient 
annealing temperature without any additives. The required gene was carefully excised 
from the agarose gel and the samples were purified by using a QIAquick PCR Purification 
Kit.  
 
4.1.3 Restriction digestion 
 Restriction digestion is a process of cleaving the DNA fragment at specific 
sequences (restriction sites) recognized by a type of enzyme called a restriction enzyme. 
These enzymes are named after the bacteria from which they were isolated. Purified PCR 
products containing inserted restriction sites on either ends were digested with respective 
enzymes to create cohesive ends that are compatible to the MCS in pQE-80L plasmid 
(Figure 4.1).  
 The digested samples were purified from 0.6% agarose gel using QIAquick Gel 
Extraction kit protocol to obtain relatively pure DNA, which is essential for a ligation 
experiment.  Ligation is a process of covalently linking two ends of a DNA fragment or 
two DNA fragments at their ends. Chemically, it is the formation of a phosphodiester 
bond between 3’ hydroxyl group of one nucleotide and the 5’ phosphate group of the 
other nucleotide. This reaction was catalyzed by an enzyme called T4 DNA Ligase in 
presence of Mg
2+
 and ATP at room temperature. The digested PCR products were ligated 
into their corresponding vectors according to the procedure mentioned in section 3.4.5.  
 Diagrams of all the genes showing 5’ and 3’ cohesive ends after digestion and 
pQE-80L with a part of its DNA sequence showing the transcription start site, sequence 
for 6x-His Tag, MCS, and transcription stop codons are indicated in Figure 4.2, and the 
DNA maps of the recombinant constructs showing start of transcription, 6X-His Tag and 
the cloning sites for each gene are indicated in Appendix-B. The recombinant constructs 
so prepared were transformed into a suitable host, for its maintenance and efficient 
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overexpression of the protein. Hence, pQE-80L-Lp_iolG1, pQE-80L-Lp_iolG2, pQE-
80L-Lp_iolG3, pQE-80L-Lp_iolG4, pQE-80L-Lc_iolG1 and pQE-80L-Lc_iolG2) were 
transformed into E. coli XL1 Blue and/or BL21 Gold competent cells as described in 
section 3.3.6. 
 
 
Figure 4.2: A). PCR products after restriction digestion (5’- and 3’- overhangs at the ends of each gene 
are shown in different colors that are matching with MCS of pQE-80L. B). pQE-80L vector showing the 
DNA sequence of important regions (starting from the transcription start codon to the stop codons, is 
shown). MCS is located at 3’ end of the 6X-His Tag sequence and the sequences for each restriction 
enzyme were highlighted in different colors. The diagrams were prepared using ChemDraw Pro 12.0 
Version. 
 
 
4.1.4 Screening and selection of viable clones 
 Successfully transformed E. coli host cells were verified for the presence of a 
properly ligated gene sequence in pQE-80L. The native pQE-80L and the recombinant 
constructs were isolated from the host cells. Restriction digestion was performed with 
selected restriction enzymes. 
 pQE-80L has a single EcoRV restriction site at 1530 bp in its sequence and 
Lp_iolG1 also has the same site at 654 bp towards the 3’ end. The insertion of Lp_iolG1 
into pQE-80L has resulted in two EcoRV sites at 804 bp and 2540 bp, and thus EcoRV 
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digestion of pQE-80L (4751 bp) resulted in a single DNA fragment of 4751 bp, while 
pQE-80L-Lp_iolG1 (5761 bp) resulted in two DNA fragments of 4025 bp and 1736 bp as 
shown in Figure 4.3(A). An agarose gel showing the corresponding DNA fragments of 
digested pQE-80L and pQE-80L-Lp_iolG1 is indicated in Figure 4.3(B).  
 
 
 
  
 
 
 
 
 
 
 
 
Figure 4.3: A). Restriction DNA map of pQE-80L and pQE-80L-Lp_iolG1 showing restriction site for 
EcoRV enzyme. The image was generated using DNA Dynamo software. B). A GelRed™ stained 1% 
agarose gel showing the DNA bands of pQE-80L and pQE-80L-Lp_iolG1 digested with EcoRV enzyme 
(Lane M:1Kb plus DNA marker; Lane 1: pQE-80L and Lane 2: pQE-80l-Lp_iolG1). 
 
 Similarly, pQE-80L has a single EcoRI restriction site at 88 bp in its sequence and 
the Lp_iolG2 also has the same site at 862 bp towards the 3’ end. The insertion of 
Lp_iolG2 into pQE-80L has resulted in two EcoRI sites at 88 bp and 1012 bp, and thus 
EcoRI digestion of pQE-80L (4751 bp) resulted in a single DNA fragment of 4751 bp, 
while pQE-80L-Lp_iolG1 (5804 bp) resulted in two DNA fragments of 4880 bp and 924 
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bp as shown in Figure 4.4(A). An agarose gel showing the corresponding DNA 
fragments of digested pQE-80L and pQE-80L-Lp_iolG1 is indicated in Figure 4.4(B).  
 
 
 
Figure 4.4: A). Restriction DNA map of pQE-80L and pQE-80L-Lp_iolG2 showing restriction site for 
EcoRI enzyme. The image was generated using DNA Dynamo software. B). A GelRed™ stained 1% 
agarose gel showing the DNA bands of pQE-80L and pQE-80l-Lp_iolG1 digested with EcoRI enzyme 
(Lane M:1Kb plus DNA marker; Lane 1: pQE-80L and Lane 2: pQE-80L-Lp_iolG2). 
 
 The NcoI enzyme cuts pQE-80L at a single site at 860 bp while it cuts pQE-80L-
iolG3 at two sites at 149 bp and 1872 bp as shown in Figure 4.5(A). Hence, NcoI 
digestion of pQE-80L (4751 bp) resulted in a single DNA fragment of 4751 bp, while 
pQE-80L-Lp_iolG3 (5763 bp) resulted in two DNA fragments of 4040 bp and 1723 bp. 
An agarose gel showing the corresponding DNA fragments of digested pQE-80L and 
pQE-80L-Lp_iolG3 is indicated in Figure 4.5(B). 
43 
 
 
 
 
Figure 4.5: A). Restriction DNA map of pQE-80L and pQE-80L-Lp_iolG3 showing restriction site for 
NcoI enzyme. The image was generated using DNA Dynamo software. B). A GelRed™ stained 1% 
agarose gel showing the DNA bands of pQE-80L and pQE-80l-Lp_iolG3 digested with NcoI enzyme 
(Lane M:1Kb plus DNA marker; Lane 1: pQE-80L and Lane 2: pQE-80L-Lp_iolG3). 
 
 The EcoRV digestion maps for pQE-80L and pQE-80L-Lp_iolG4 are shown in 
Figure 4.6(A). In this digestion, the pQE-80L (4751 bp) resulted in a single DNA 
fragment of 4751 bp, while pQE-80L-Lp_iolG4 (5766 bp) resulted in two DNA 
fragments of 3521 bp and 2245 bp. An agarose gel showing the corresponding DNA 
fragments of digested pQE-80L and pQE-80L-Lp_iolG4 is indicated in Figure 4.6(B).  
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Figure 4.6: A). Restriction DNA map of pQE-80L and pQE-80L-Lp_iolG4 showing restriction site for 
EcoRV enzyme. The image was generated using DNA Dynamo software. B). A GelRed™ stained 1% 
agarose gel showing the DNA bands of pQE-80L and pQE-80l-Lp_iolG1 digested with EcoRV enzyme 
(Lane M:1Kb plus DNA marker; Lane 1: pQE-80L and Lane 2: pQE-80L-Lp_iolG4). 
 
 The insertion of Lc_iolG1 into pQE-80L has resulted in two NcoI sites as shown 
in Figure 4.7(A). Hence, NcoI digestion of pQE-80L (4751 bp) resulted in a single DNA 
fragment of 4751 bp, while pQE-80L-Lc_iolG1 (5775 bp) resulted in two DNA 
fragments of 4040 bp and 1735 bp. An agarose gel showing the corresponding DNA 
fragments of digested pQE-80L and pQE-80L-Lp_iolG1 is indicated in Figure 4.7(B).  
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Figure 4.7: A). Restriction DNA map of pQE-80L and pQE-80L-Lc_iolG1 showing restriction site for 
NcoI enzyme. The image was generated using DNA Dynamo software. B). A GelRed™ stained 1% 
agarose gel showing the DNA bands of pQE-80L and pQE-80l-Lc_iolG1 digested with NcoI enzyme 
(Lane M:1Kb plus DNA marker; Lane 1: pQE-80L and Lane 2: pQE-80L-Lc_iolG1). 
 
 pQE-80L-Lc_iolG2 (5776 bp) clones were verified by KpnI digestion. The KpnI 
digestion maps for pQE-80L and pQE-80L-Lc_iolG4 are shown in Figure 4.8(A). Here, 
the pQE-80L has a single cut site at 167 bp for kpnI enzyme, but has none in pQE-80L-
Lc_iolG2 as a result pQE-80L shows a single DNA band of size 4751 bp while pQE-80L-
Lc_iolG2 appears as an uncut vector on the agarose gel Figure 4.8(B). Finally, DNA 
sequencing had confirmed the successful cloning of all genes encoding IDH-related 
enzymes. 
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Figure 4.8: A). Restriction DNA map of pQE-80L and pQE-80L-Lc_iolG2 showing restriction site for 
KpnI enzyme. The image was generated using DNA Dynamo software. B). A GelRed™ stained 1% 
agarose gel showing the DNA bands of pQE-80L and pQE-80L-Lc_iolG2 digested with KpnI enzyme 
(Lane M:1Kb plus DNA marker; Lane 1: pQE-80L and Lane 2: pQE-80L-Lc_iolG2). 
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4.2   Gene expression 
 To identify the expression of all the genes, the crude cell lysates were analyzed by 
a 12% SDS-polyacrylamide gel electrophoresis as shown in Figure 4.9.  
 
 
Figure 4.9: A Coomassie Brilliant-Blue stained 12% SDS Polyacrylamide gel showing crude cell 
lysates of IDH-related enzymes (Lane M: Low-range protein marker; Lane 1: LpIDH1, Lane 2: LpIDH2, 
Lane 3: LpIDH3, Lane 4: LpIDH4, Lane 5: LcIDH1 and Lane 6: LcIDH2). 
 
 From Figure 4.9, it is apparent that all the IDH-related genes, except Lp_iolG2, 
were able to express soluble proteins. The expression of Lp_iolG2 had resulted in the 
formation of inclusion bodies or protein aggregates. Protein misfolding, alterations in the 
primary protein sequence as a result of mutations, or translational misincorporation of the 
amino acid residues are the possible reasons for protein aggregation (86, 87). Formation 
of inclusion bodies affects the solubility and the stability of the expressed protein. 
Therefore, expression and purification of LpIDH2 was unsuccessful.  
  
4.3   Protein isolation and purification 
 IDH-related enzymes from L. plantarum WCFS1 (LpIDH1, LpIDH3 & LpIDH4), 
L. casei BL23 (LcIDH1 & LcIDH2) and BsIDH were isolated as crude extracts from 
their respective cell pellets and purified separately using HiTrap-IMAC FF 1 mL columns 
as mentioned in section 3.5. Immobilized-metal affinity chromatography (IMAC) method 
was first introduced in 1975 (88).The metal-chelating ligand iminodiacetic acid was 
charged with divalent metal cations such as Zn
2+
, Cu
2+
 and Ni
2+
 to purify different 
proteins and peptides (89). Here, Nickel (Ni
2+
) provided good binding affinity to the 
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hexahistidine tag at the N-terminal region of all these expressed proteins. However, 
binding of other non-specific proteins containing histidine clusters was obvious. Hence, 
the crude protein extracts were prepared in binding buffer containing 10 mM imidazole, 
as it minimizes binding of nonspecific proteins onto the column. Imidazole at 60 mM 
concentration in wash buffer was used to further remove the non-specific proteins (along 
with small amounts of desired protein) from the column. EDTA (metal chelator) at 100 
mM concentration was used to elute pure proteins from the column. Protein dialysis using 
a 25 kDa MWCO dialysis membrane has provided maximum purity. A 10% (v/v) 
glycerol and 0.5 M NaCl was maintained throughout the purification process and 40% 
(v/v) glycerol and 0.1 mM 1, 4-dithio-D-threitol (DTT) in the dialysis buffer to prevent 
protein precipitation, especially at higher concentrations, and to maintain stability.  
 As described in section 3.5.1, LpIDH2 was purified from inclusion bodies using a 
previously reported method (90). The bacterial cell pellet containing LpIDH2 inclusion 
bodies were solubilized using 8M urea. Bacterial cell debris was separated by 
centrifugation; the denatured protein sample was filtered and dialyzed against the 
refolding buffer. The dialysis process was done for 2 days with regular buffer changes, to 
ensure proper refolding of proteins. During dialysis some of the non-specific proteins and 
small peptides were separated. The refolded LpIDH2 was further purified by using 
HiTrap-IMAC FF 1 mL column. The pure protein fractions were pooled together and 
dialyzed against the regular dialysis buffer as described in section 3.5. In order to show 
that a refolded enzyme can be active, BsIDH was also purified by this method and 
assayed.  
 The concentration of all the proteins was determined by A280 method as described 
in section 3.6.2. Approximately 300 mg of LcIDH1 and 500 mg of LcIDH2 were purified 
from 1 L and 2 L bacterial cultures respectively. A Coomassie Brilliant-blue stained 12% 
SDS-polyacrylamide gel showing the purified LpIDH1, LpIDH3, LpIDH4, LcIDH1, 
LcIDH2 and BsIDH is indicated in Figure 4.10. 
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Figure 4.10: A Coomassie Brilliant-Blue stained 12% SDS Polyacrylamide gel showing the purified 
IDH-related enzymes (Lane M: Low-range protein marker; Lane 1: LpIDH1; Lane 2: LpIDH3; Lane 3: 
LpIDH4; Lane 4: LcIDH1; Lane 5: LcIDH2 and Lane 6: BsIDH). 
 
 
4.4 Enzyme kinetics 
4.4.1 Inositol dehydrogenase activity  
 BsIDH from Bacillus subtilis catalyses the first step in myo-inositol catabolism 
and optimal conditions for its activity have been reported earlier (56). Accordingly, the 
soluble enzymes from L. plantarum WCFS1 (LpIDH1, LpIDH3 & LpIDH4) and L. casei 
BL23 (LcIDH1, LcIDH2) were tested for myo-inositol dehydrogenase activity at 50 mM 
myo-inositol and 2 mM NAD
+
 in 100 mM Tris-HCl pH 9.0 at 25 
o
C as described in 3.8.1. 
Surprisingly, IDH-related enzymes from L. plantarum WCFS1 (LpIDH1, LpIDH3 & 
LpIDH4) did not exhibit any activity when assayed with myo-inositol, but LcIDH1 and 
LcIDH2 from L.casei BL23 showed dehydrogenase activity similar to BsIDH. When 
NAD
+
 was replaced with NADP
+
, all enzymes failed to show inositol dehydrogenase 
activity, suggesting that they are exclusively NAD
+
-dependent inositol dehydrogenases as 
reported for BsIDH (56, 58). The absorbance versus time plots showing the activities of 
IDH-related enzymes with myo-inositol and NAD
+
 is indicated in Figure 4.11. 
 Inositol dehydrogenase activity was also tested for the LpIDH2 and BsIDH that 
were purified by unfolding and refolding experiments. LpIDH2 did not exhibit any 
activity. However, BsIDH showed significantly less activity when compared to that of 
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BsIDH purified by normal method. An absorbance versus time plots showing the 
activities of unfolded and refolded LpIDH2 and BsIDH with 50 mM myo-inositol and  
2 mM NAD
+
 is indicated in Figure 4.12. 
 
 
Figure 4.11: Absorbance vs time plot showing the activities of BsIDH and IDH-related enzymes from 
L. plantarum WCFS1 and L. casei BL23. Conditions: 50 mM myo-inositol, 2 mM NAD
+
, 100 mM Tris-
HCl pH 9.0 at 25 
o
C, (●) BsIDH, (■) LcIDH1, (▲) LcIDH2, (♦) LpIDH1, (□) LpIDH3 and (×) LpIDH4. 
The amount of enzyme in each reaction was 1 µL of 1 mg/mL. 
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Figure 4.12: Absorbance vs time plot showing the activities of BsIDH and LpIDH2 purified by 
unfolding and refolding experiment. Conditions: 50 mM myo-inositol, 2 mM NAD
+
, 100 mM Tris-HCl 
pH 9.0 at 25 
o
C, (■) BsIDH purified by normal method, (◊) BsIDH purified by unfolding and refolding 
method, (○) LpIDH2 purified by unfolding and refolding method. The amount of enzyme in each reaction 
was 1 µL of 1 mg/mL concentration. 
 
4.4.2 Optimum pH and pH-rate profiles 
The pH (a measure of H
+
 ion concentration) can influence the structure and 
activity of an enzyme. A change in pH can influence the state of ionization of acidic or 
basic amino acid side chains in the active site, which can lead to either loss of substrate 
recognition by the enzyme or failure to convert substrates into products. Extremely high 
or low pH conditions can disrupt the three-dimensional conformations of a protein 
making it completely inactive. Therefore, it is important to determine the optimum pH for 
an enzyme-catalyzed reaction before performing kinetic studies.  
The optimum pH for the reactions catalyzed by LcIDH1, LcIDH2 and BsIDH 
were determined according to the procedure described in section 3.8.3. The pH-rate 
profiles for LcIDH1 and LcIDH2 are indicated in Figures 4.13 and 4.14 respectively. 
From the pH-rate profiles, it is clear that LcIDH1 has a maximum activity at pH 9.3 while 
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LcIDH2 has a maximum activity at pH 9.5, when measured at 50 mM myo-inositol and 2 
mM NAD
+
, in 100 mM 2-(cyclohexylamino)-ethanesulfonic acid, CHES (buffer pH 
range: 8.6-10) at 25
o
C.  
The pH-rate profile for BsIDH was determined to compare the maximum 
activities of LcIDH1 and LcIDH2 with that of BsIDH. The pH-rate profile for BsIDH 
was previously reported and the kinetic studies were performed in Tris-HCl pH 9.0 (56, 
61). According to the reported pH profile, Tris-HCl buffer was used for the reactions that 
were performed at pH greater than 9.0. However, the useful pH range for Tris-HCl is 7.0-
9.0, which suggests that Tris-HCl cannot show its buffering capacity beyond this range. 
This could be the possible reason for decrease in forward reaction rates after pH 9.0 that 
was observed in the pH-rate profile of BsIDH. In this research, the pH-rate profile for 
BsIDH was established as described in section 3.8.3. BsIDH showed maximum activity 
at pH 10.0, when assayed in 100 mM glycine-NaOH buffer (buffer pH range: 8.8-10.6) at 
25
o
C. In buffer comparison experiments, LcIDH1 and LcIDH2 showed higher activities 
in CHES than glycine-NaOH and BsIDH showed higher activity in glycine-NaOH than 
CHES and Tris-HCl, see Figure 4.15. Note that the activity below pH 9.0 was much 
lower. 
 
 
Figure 4.13: The pH-rate profile of LcIDH1. Conditions: 50 mM myo-inositol, 2 mM NAD
+
 and 100 
mM buffer (●) CHES, (○) glycine-NaOH at 25 oC. 
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Figure 4.14: The pH-rate profile of LcIDH2. Conditions: 50 mM myo-inositol, 2 mM NAD
+
 and 100 
mM buffer (■) CHES, (□) glycine-NaOH at 25 oC. 
 
 
 
 
Figure 4.15: The pH-rate profile of BsIDH. Conditions: 50 mM myo-inositol, 2 mM NAD
+
 and 100 mM 
buffer (▲) glycine-NaOH, (∆) CHES, and (♦) Tris-HCl at 25 oC. 
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4.4.3 True kinetic constants (Km , kcat and kcat/Km ) 
 True kinetic constants for the reaction catalyzed by LcIDH1, LcIDH2 and BsIDH 
were determined according to the procedure described in section 3.8.4. The initial 
velocity data was calculated as described in section 3.8.2. Leonora software was used to 
generate the true kinetic constants (80). Leonora uses a non-linear least-squares method 
to fit the initial velocity data to Equation 3.3 in 3.8.4 assuming there is no product 
accumulation and generates the kinetic constants, Km (for both substrates), and Ki for 
NAD
+
. The turnover number, kcat was calculated using the Vmax and total enzyme 
concentration Et, while the specificity constant, kcat/Km was calculated using kcat and Km 
values. Michaelis-Menten saturation curves and double reciprocal plots (Lineweaver-
Burk Plots) for LcIDH1, LcIDH2 and BsIDH are indicated in Appendix-C. True kinetic 
constants for LcIDH1, LcIDH2 and BsIDH with myo-inositol and NAD
+
, and LcIDH1 
with D-glucose and NAD
+
 are indicated in Table 4.1.  
 
Table 4.1: True kinetic constants for LcIDH1, LcIDH2 and BsIDH  
Kinetic constants LcIDH1 LcIDH2 BsIDH 
myo-inositol:  
      
Vmax (nM/s) 382 ± 4 71 ± 3 (15.5 ± 0.6) × 10
3
 
Km (NAD
+
) (mM) 0.55 ± 0.02 0.03 ± 0.02 0.23 ± 0.04 
Km(myo-inositol)(mM) 1.7 ± 0.3 6.7 ± 0.9 3.1 ± 0.7 
kcat (s
-1
) 13.2 ± 0.2 1.8 ± 0.1 294 ± 16 
kcat/Km (NAD
+
) (M
-1
 s
-1
) (24 ± 1) × 10
3
 (50 ± 9) × 10
3
 (1277 ± 62) × 10
3
 
kcat/Km (myo-inositol) (M
-1
 s
-1
) (7.8 ± 1.4) × 10
3
 (0.26 ± 0.038) × 10
3
 (96 ± 5) × 10
3
 
Ki (NAD
+
) 8.3 ± 0.2 14.5 ± 0.7 10.3 ± 0.6 
D-glucose: 
   Vmax (nM/s) 1670 ± 160 
Not  
determined 
Not  
determined 
Km (NAD
+
) (mM) 0.61 ± 0.13 
Km(D-glucose)(mM) 19.5 ± 11.7 
kcat (s
-1
) 4.9 ± 0.5 
kcat/Km (NAD
+
) (M
-1
 s
-1
) (7.96 ± 1.83) × 10
3
 
kcat/Km (D-glucose) (M
-1
 s
-1
) 250 ± 16 
Ki (NAD
+
) 4.1 ± 0.5 
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From the double reciprocal plots (see appendix-B), it can be observed that the trend lines 
representing the data points intersects on the left side of the y-axis, which suggests that 
LcIDH1 and LcIDH2 follow a sequentially ordered Bi-Bi mechanism similar to that 
reported for BsIDH (56, 58). The kinetic results shown in Table 4.1, suggests that 
LcIDH1 and LcIDH2 from L. casei BL23 exhibit very different inositol dehydrogenase 
activities.  The Km value for LcIDH1 is 4 times lower and the kcat value 7.3 times higher 
when compared to that of LcIDH2. These differences make LcIDH1 a more efficient 
enzyme for the oxidation of myo-inositol, as indicated by its specificity constant value, 
which is nearly 30 times higher compared to LcIDH2. By comparing the true kinetic 
constants of LcIDH1 to that of BsIDH, it can be observed that LcIDH1 is a much less 
efficient enzyme, and this difference is seen almost entirely in the turnover number (kcat). 
LcIDH2 showed 2-fold higher value of Km and almost 150-fold smaller kcat value when 
compared to BsIDH. By comparing the true kinetic constants with myo-inositol and D-
glucose, it is apparent that LcIDH1 oxidize D-glucose with less efficiency, suggesting 
myo-inositol is the preferred substrate. 
 
4.4.4 Exploring alternate substrates 
 It was reported that BsIDH can stereoselectively oxidize other structurally related 
compounds in addition to myo-inositol (section 1.4) (56, 58, 59). Further, assays showed 
that LpIDH1, LpIDH3 and LpIDH4 from L. plantarum WCFS1 are inactive when myo-
inositol was used as the substrate. Therefore, it was hypothesized that IDH-related 
enzymes from L. plantarum WCFS1 and L.casei BL23 may also exhibit a broad substrate 
spectrum. To investigate this, the dehydrogenase activity assays were performed with 
compounds such as scyllo-inositol, D-chiro-inositol, D-glucose, L-glucose and D-xylose, 
D-galactose, D-mannose, D-sorbitol, D-mannitol, scyllo-inosose and 4-O-benzyl-myo-
inositol. Each assay was performed at 50 mM substrate and 2 mM NAD
+
 in 100 mM 
Tris-HCl pH 9.0, CHES pH 9.3 and 9.5, and glycine-NaOH pH 10.0. The activity of 
BsIDH was also tested with these compounds. The compounds that are tested in this 
study are indicated in Figure 4.16. Further, apparent kinetic constants were determined 
for the compounds with which the IDH-related enzymes showed activity. 
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.  
Figure 4.16: myo-Inositol and other related compounds tested for dehydrogenase activity   
 
 
4.4.4.1 Apparent kinetics constants 
  Apparent kinetic constants were calculated for the active IDH-related enzymes 
with the compounds that are recognized as the substrates. Kinetic assays were performed 
as described in section 3.8.5. The initial velocity data was fitted to Equation 3.4 using 
Leonora. Kinetic assays with 4-O-benzyl-myo-inositol were performed in 20% DMSO as 
reported previously (60). Michaelis-Menten saturation curves and the Lineweaver-Burk 
plots for LcIDH1 with different substrates are provided in Appendix-D. Apparent kinetic 
constants for LcIDH1 with different substrates are indicated in Tables 4.2. 
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Table 4.2: Apparent kinetic constants for LcIDH1 
Substrates 
Vmax
app
   
(nM/s) 
Km
app  
(mM) 
kcat
app
  
(s
-1
) 
(kcat/Km)
app
  
(M
-1
 s
-1
) 
myo-inositol  300 ± 1 7.0 ± 0.1 10.3 ± 0.7 1500 ± 100 
D-chiro-inositol 173 ± 6 47 ± 3 5.9 ± 0.4 130 ± 10 
D-glucose 115 ± 10 31 ± 8 3.9 ± 0.4 130 ± 40 
D-xylose 
 
165 ± 7 225 ± 23 5.7 ± 0.2 25 ± 3 
4-O-benzyl-myo-inositol* 75 ± 3 28 ± 2 1.9 ± 0.1 33 ± 2 
Note: * = The reaction was performed in 20% DMSO in 100 mM CHES pH 9.3 
 
  Michaelis-Menten saturation curves and the Lineweaver-Burk plots for LcIDH2 
with different substrates are indicated in Appendix-D. Apparent kinetic constants of 
LcIDH2 with different substrates are indicated in Tables 4.3. 
 
Table 4.3: Apparent kinetic constants of LcIDH2 
Substrates 
Vmax
app
   
(nM/s) 
Km
app  
(mM) 
kcat
app
  
(s
-1
) 
(kcat/Km)
app
  
(M
-1
 s
-1
) 
myo-inositol  67 ± 2 12.2 ± 1.3 1.7 ± 0.1 135 ± 15 
D-chiro-inositol 24 ± 2 527 ± 58 0.6 ± 0.1 1.1 ± 0.1 
D-glucose 64 ± 1 181 ± 6 1.6 ± 0.1 8.8 ± 0.4 
D-xylose  
 
42.4 ± 0.6 142 ± 6 1.1 ± 0.1 7.4 ± 0.3  
4-O-benzyl-myo-inositol* No Activity 
scyllo-inositol 71.4 ± 0.4 0.35 ± 0.07 1.8 ± 0.1 5000 ± 150 
L-glucose 48.6 ± 1.4 108 ± 5 1.21 ± 0.03 11.2 ± 0.4 
Note: * = The reaction was performed in 20% DMSO in 100 mM CHES pH 9.5. 
 
  Michaelis-Menten saturation curves and the Lineweaver-Burk plots for BsIDH 
with different substrates are indicated in Appendix-D. Apparent kinetic constants for 
BsIDH with different substrates are indicated in Tables 4.4. 
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Table 4.4: Apparent kinetic constants of BsIDH 
Substrates 
Vmax
app
   
(nM/s) 
Km
app  
(mM) 
kcat
app
  
(s
-1
) 
(kcat/Km)
app
  
(M
-1
 s
-1
) 
myo-inositol  14700 ± 100 7.9 ± 0.1 270 ± 2 34200 ± 500 
D-chiro-inositol 1200 ± 20 18 ± 1 22.02 ± 0.02 1220 ± 68 
D-glucose 678.1 ± 14.3 60.5 ± 2.3 12.4 ± 0.3 205 ± 9 
D-xylose 
 
1210 ± 30 200 ± 8 22.2 ± 0.5 111 ± 5 
4-O-benzyl-myo-inositol* 389 ± 5 11.2 ± 0.5 15.1 ± 0.2 1310 ± 60 
Note: * = The reaction was performed in 20% DMSO in 100 mM glycine-NaOH pH 10. 
 
  Apparent kinetic constants for LcIDH1, LcIDH2 and BsIDH with different 
substrates are graphically represented for convenient comparison. Figure 4.17 represents 
the comparison of kcat values and Figure 4.18 represents the comparison of the specificity 
constants values. 
 
Figure 4.17: Comparison of apparent kcat values of BsIDH, LcIDH1 and LcIDH2 with different 
substrate. Assay conditions: 50 mM substrate, 2 mM NAD
+
 and 100 mM glycine-NaOH pH 10 (BsIDH); 
100 mM CHES pH 9.3 (LcIDH1) and pH 9.5 (LcIDH2). 
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Figure 4.18: Comparison of specificity constants of BsIDH, LcIDH1 and LcIDH2 with different 
substrate. Assay conditions: 50 mM substrate, 2 mM NAD
+
 and 100 mM glycine-NaOH pH 10 (BsIDH); 
100 mM CHES pH 9.3 (LcIDH1) and pH 9.5 (LcIDH2). 
 
 IDH-related enzymes from L. plantarum WCFS1 did not show activity with any 
of the compounds (Figure 4.16) tested. As described in section 1.5.1, LpIDH1 showed 
activity with scyllo-inosose, which is the product in the first step of myo-inositol 
catabolism. Recently, IDH-related enzymes were classified into four subgroups and 
proposed that IDH enzymes from L. plantarum WCFS1 are different to each other in 
their sequence and structure. Each of the four enzymes belongs to a different IDH 
subgroup (63). Except for LpIDH1, there is no structural information for these enzymes. 
Therefore, the protein sequences of these enzymes were compared to sequence and 
structure of BsIDH by a multiple sequence alignment approach, to predict the activity 
differences between these enzymes. 
  LcIDH1 activity is very similar to BsIDH, in that both BsIDH and LcIDH1 
showed activity with D-chiro-inositol, D-glucose, D-xylose, and 4-O-benzyl-myo-inositol 
in addition to myo-inositol, but were unable to show any activity with compounds such as 
scyllo-inositol, and L-glucose. For both BsIDH and LcIDH1 myo-inositol is the natural 
substrate as indicated by their high apparent specificity constant values (Table 4.2 and 
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4.4) compared to the other substrates. The apparent specificity constant for the oxidation 
of D-chiro-inositol is nearly equal to that of 4-O-benzyl-myo-inositol for BsIDH. LcIDH1 
catalyzed the oxidation of D-chiro-inositol and D-glucose with equal efficiency. Both 
enzymes are least active with D-xylose. This is because of a very high value of Km
app
 and 
a low apparent turnover number (Table 4.2 and 4.4). The oxidation of 4-O-benzyl-myo-
inositol by LcIDH1 suggests that it also possess a hydrophobic pocket next to the active 
site similar to BsIDH, and the sequence alignment of LcIDH1 with BsIDH indicates that 
residues proposed for this hydrophobic pocket are conserved (Figure 1.4). It was 
proposed that the Y235 or W272 make stacking interactions with the benzyl group when 
4-O-benzyl-myo-inositol binds in the active site (60). These observations suggest that 
LcIDH1 has a broad substrate spectrum and stereoselectivity similar to BsIDH.  
 LcIDH2 activity is quite different from BsIDH and LcIDH1 activities. It oxidized 
scyllo-inositol, and L-glucose in addition to myo-inositol, D-chiro-inositol, D-glucose, D-
xylose, but no activity was observed with 4-O-benzyl-myo-inositol. From Figure 4.17, it 
is apparent that the kcat
app
 values for the oxidation of scyllo-inositol, myo-inositol, and D-
glucose are nearly equal. However, the apparent specificity constant for scyllo-inositol is 
37 times and 570 times higher when compared to myo-inositol and D-glucose 
respectively, (Figure 4.18). These differences can be seen entirely in large variations in 
Km
app
 values of LcIDH2 towards these substrates (Table 4.3). The apparent specificity 
constants for the oxidation of D-xylose and D-glucose are nearly equal and are 
comparable to that of L-glucose, which is the enantiomer of D-glucose. This suggests that 
the active site of LcIDH2 is structurally different from LcIDH1 and BsIDH. A very high 
Km
app
 and a much low apparent turnover number (Table 4.3) make LcIDH2 much less 
efficient for the oxidation of D-chiro-inositol. The loss of activity with 4-O-benzyl-myo-
inositol suggests that LcIDH2 does not accommodate the 4-O-substituted inositol 
derivatives as its substrates and the active site of LcIDH2 is different from that of 
LcIDH1 and BsIDH.  It was reported that the C2 hydroxyl group of myo-inositol is 
oxidized by BsIDH (56). Since LcIDH2 is able to oxidize scyllo-inositol and myo-
inositol, it is not clear which hydroxyl group is the target during the oxidation of these 
substrates and also other substrates. Furthermore, the true kinetic constants were 
determined for scyllo-inositol and compared with those of myo-inositol. Michaelis-
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Menten saturation curves, and the Lineweaver-Burk plots are shown in Appendix-C and 
the kinetic data is shown in Table 4.5. 
Table 4.5: True kinetic constants of LcIDH2 with myo-inositol and scyllo-inositol 
inetic constants myo-inositol (MI) scyllo-inositol (SI) 
Vmax (nM/s) 71 ± 3 76 ± 2 
Km (NAD
+
) (mM) 0.09 ± 0.01 0.11 ± 0.02 
Km (S) (mM) 6.7 ± 0.9 0.12 ± 0.02 
kcat (s
-1
) 1.8 ± 0.1 1.9 ± 0.1 
kcat/Km (NAD
+
) (M
-1
 s
-1
) (20 ± 3) × 10
3
 (17.3 ± 0.2) × 10
3
 
kcat/Km (S) (M
-1
 s
-1
) 261 ± 38 (15.8 ± 0.2) × 10
3
 
Ki (NAD
+
) 14.5 ± 0.7 0.29 ± 0.02 
 
From Table 4.5, the values for Vmax, kcat, Km (NAD
+
) and kcat/Km (NAD
+
) looks 
similar, but a significant difference in Km and the specificity constant, kcat/Km can be 
observed between these substrates. The Km for scyllo-inositol is 0.12 mM, which is 60 
times less when compared to the Km for myo-inositol. The specificity constant, kcat/Km for 
scyllo-inositol is also very high relative to that for myo-inositol. On the basis of these 
differences, it is conclusive that LcIDH2 has 60 times higher binding affinity for scyllo-
inositol than myo-inositol and LcIDH2 can catalyze the oxidation of scyllo-inositol with 
high efficiency compared to the oxidation of myo-inositol.  
 
4.4.5 Preparation of  scyllo-inosose, 2-2H-myo-inositol, and myo-inositol 
   scyllo-Inosose was prepared from the commercial myo-inositol as described in 
section 3.2.1. scyllo-Inosose was produced as a white solid when Gluconobacter oxydans 
ATCC # 621H was cultured in revitalizing media containing myo-inositol for 96 h and 
followed by methanol precipitation. The product was confirmed by 
1
H NMR and melting 
point, which are close to the previously reported once. 
   Sodium borodeuteride (NaB
2
H4) reduced the carbonyl group of scyllo-inosose to 
produce 2-
2
H-myo-inositol. The deuterium atom was stereoselectively added on to the 
C2, which is anti to the hydroxyl groups on the adjacent carbon atoms. The pure 2-
2
H-
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myo-inositol was obtained after acetylation and deacetylation steps. Similarly, reduction 
of scyllo-inosose with NaBH4 resulted in myo-inositol. Scheme 4.1 represents different 
steps in the preparation of scyllo-inosose, 2-
2
H-myo-inositol and myo-inositol. 
 
 
Scheme 4.1: Preparation of scyllo-inosose, 2-
2
H-myo-inositol, and myo-inositol. a) G. oxydans ATCC # 
621H, 30 
o
C, 96 h. b) (1) NaBD4, ddH2O, r. t., overnight; (2) Ac2O, pyridine, 100
o
C 24 h; (3) NaOCH3, 
CH3OH, reflux 20 min, Dowex 50X8 (H
+
 form) 200-400 mesh, acetone wash. c) (1) NaBH4, ddH2O, r. t., 
overnight; (2) Ac2O, pyridine, 100
o
C 24 h; (3) NaOCH3, CH3OH, reflux 20 min, Dowex 50X8 (H
+
 form) 
200-400 mesh, acetone wash. 
 
 
4.4.6 Kinetic isotopic effect (KIE) 
 According to a sequentially ordered Bi-Bi mechanism, the enzyme first binds to 
the coenzyme NAD
+
 followed by myo-inositol or other related compounds and forms a 
ternary-complex, (E-NAD
+
-Substrate) (70). During this ternary-complex state, the 
conversion of substrates into products or vice-versa constitutes the chemical step of the 
reaction. After catalysis the ternary-complex breaks down, first releasing scyllo-inosose 
followed by NADH in the forward reaction. A detailed kinetic mechanism for BsIDH has 
been determined and demonstrated that the chemical step (hydride transfer) is not the 
rate-limiting step, but the breakdown of the ternary-complex and the liberation of NADH 
limits the rate of the reaction (58). Later, this was confirmed by kinetic isotopic effect 
studies (61).  
 In this research, the kinetic results suggest that LcIDH1 and LcIDH2 may follow 
a sequentially ordered Bi-Bi mechanism during catalysis. However, LcIDH1 exhibited 
less efficiency when compared to BsIDH. It was assumed that the chemical step might be 
responsible for the reduced activity. Therefore, a primary kinetic isotopic effect 
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experiments for LcIDH1 were performed to identify the rate-limiting step, using 
commercial myo-inositol, and synthetic myo-inositol and 2-
2
H-myo-inositol. The latter 
compounds were prepared according to previously described methods (61). The apparent 
kinetics constants for LcIDH1 were determined as described in section 3.8.5 and the 
results are indicated in Table 4.6 and the Michaelis-Menten saturation curves and the 
double reciprocal plots were indicated in Appendix-E. 
 
Table 4.6: Apparent kinetic constants for LcIDH1 with commercial 
myo-inositol and the synthetic myo-inositol, and 2-
2
H-myo-inositol  
Substrates Vmax
app
  (nM/s) Km
app
 (mM) 
Commercial myo-inositol 104 ± 6 5.8 ± 1.1 
Synthetic myo-inositol 116 ± 5 5.1 ± 0.1 
2-
2
H-myo-inositol 71 ± 2 4.7 ± 0.6 
 
  From the kinetic results provided in Table 4.6, the primary KIE value, [Vmax
app 
(synthetic myo-inositol)/ Vmax
app 
(2-
2
H-myo-inositol)] obtained was 1.6 ± 0.1, which is 
equal to the KIE value of 1.5 ± 0.1 obtained when assayed with commercial myo-inositol. 
Based on these results, it is apparent that the chemical step in the reaction is at least partly 
rate-limiting and this may contribute to the lower activity of LcIDH1. This is consistent 
with some other reports of dehydrogenase-catalyzed reactions, in which the primary KIE 
value for deuterium-substituted substrates is in the range of 1-2, indicating that the 
chemical step is either not rate-limiting or partially rate-limiting and the release of 
products is the primarily the rate limiting step (91-95).  
 
4.5       Rationale for sequence/structure and activity differences 
  According to the structural classification of IDH-related enzymes (section 1.5), 
there are six consensus sequence motifs that are important for coenzyme binding and the 
formation of substrate binding pocket among the IDH-related enzymes (63). Four IDH 
subgroups were classified and proposed that LpIDH1 to LpIDH4 from L. plantarum 
WCFS1 represents a member of one of the subgroup Furthermore, it was reported that 
LcIDH1 is closely related to BsIDH and LpIDH2, and LcIDH2 is related to IDH from 
Clostridia, B. cereus, and B. halodurans, Mycoplasma hyopneumoniae (mioJ1) and more 
distantly related to LpIDH1 (27). Therefore, a multiple sequence alignment of LpIDH1 to 
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LpIDH4, and LcIDH1, and LcIDH2 was performed and the aligned sequences were 
compared to the structure of BsIDH as described in section 2.6, to understand the 
sequence and activity differences between the IDH-related enzymes. A multiple sequence 
alignment result of IDH-related enzymes from L. plantarum WCFS1, and L. casei BL23 
with BsIDH is shown in Figure 4.19. 
 
 
Figure 4.19: Multiple sequence alignment of IDH-related enzymes from L. plantarum WCFS1 and L. 
casei BL23 with BsIDH. The consensus sequence motifs are highlighted in different colors, (I - blue; II – 
pink; III – orange; IV – green; V – black and VI – cyan).The active site residues K97, D172 and H178 are 
indicated with star in red. Strictly identical residues are highlighted in red background (for example X), 
similar residues are shown as red letters in blue frame. The secondary structural elements are assigned 
based in the structure of BsIDH (PDB code: 3NT4). 
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 From Figure 4.19, the major difference between the aligned sequences can be 
observed in sequence motif IV. Three alignment patterns can be observed among the 
aligned sequences. BsIDH, LpIDH2 and LcIDH1 shows a gap of 8 residues compared to 
LpIDH1 and LcIDH2. LpIDH3 and LpIDH4 are different from the above protein 
sequences. The main differences in the six sequence motifs are considered for each 
subgroup to understand the sequence and activity differences. The structure of BsIDH 
holo enzyme showing six consensus sequence motifs is shown in Figure 4.20 and the 
amino acid residues for all the proteins in each motif are shown in Figure 4.21. 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20: Structure in BsIDH (PDB code: 3NT4) showing the proposed consensus sequence motifs. 
The sequence motifs are numbered and the bound NAD
+
 and myo-inositol are indicated in yellow. 
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Figure 4.21: The proposed sequence motifs showing the amino acid residues for IDH-related 
enzymes. The active site residues are indicated with red star. 
 
 IDH subgroup I: It consists of BsIDH and LpIDH2 (63). LpIDH2 demonstrated 
43% and 39% sequence identity with BsIDH and LcIDH1 respectively. In motif IV, the 
catalytic residue at position 172 is glutamic acid instead of aspartic acid, but other 
residues, K97 and H176 and most of the amino acid residues important for coenzyme 
binding and the substrate binding are highly conserved in all six consensus sequence 
motifs suggesting that LpIDH2 may be a myo-inositol dehydrogenase enzyme for L. 
plantarum WCFS1. Unfortunately, it could not express in its soluble form..  
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 LcIDH1 demonstrated 47% sequence identity with BsIDH. In motif I, (See 
Figure 4.21) all the glycine residues are conserved, it was reported that the amide group 
of the protein chain forms hydrogen bonds with the diphosphate part of coenzyme (96, 
97). In motif II of BsIDH the amino acid sequence CEKP (residues 95-98) is important 
for the binding of ribose part of NAD/H (98). LcIDH1 contains threonine in place of 
cysteine at residue 95 and K97, one of the proposed catalytic residues for BsIDH is also 
conserved in LcIDH1. Motif III is strictly conserved. The catalytic residues D172, H176 
and most of the adjacent residues are conserved in motif IV. Further Y233, G243 and 
Y235 of motif V and W272 and most other residues of motif VI are also conserved in 
both BsIDH and LcIDH1. It was proposed that the side chain of Y235 or W272 make a 
stacking hydrophobic interaction with the substituent of 4-O-substituted-myo-inositol 
derivatives (60). Kinetic results have demonstrated that it is the real myo-inositol 
dehydrogenase enzyme for L. casei BL23. Furthermore, dehydrogenase activity with 
other substrates such as D-chiro-inositol, D-glucose, D-xylose, and 4-O-benzyl-myo-
inositol suggested that it also possesses a broad substrate spectrum similar to BsIDH. 
Although, residues that are important for coenzyme and substrate binding are conserved, 
there may be small differences in the overall structure of LcIDH1 that resulted in the less 
activity compared to BsIDH.  
  IDH subgroup II: LpIDH1 from L. plantarum WCFS1 was assigned to this 
group (63). The amino acid resides in sequence motifs I and II that are important for 
coenzyme binding and the catalytic residues K97, D172 and H178 are conserved, but the 
amino acid sequence in motif IV is different in which an extra 8 residues (GMESFTKF) 
form an α-helix 7 in LpIDH1. This α-helix 7 close the active site making it less solvent 
exposed and might prevent the substrate access into the active site Figure 4.22 (right).  
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Figure 4.22: Comparison of the structures of BsIDH (PDB code: 3NT4) and LpIDH1 (PDB code: 
3CEA) on right. BsIDH is on left and LpIDH1 is on right and the consensus sequence motif IV is 
highlighted in green.  
 
  From the Figure 4.22, it can be observed that the orientation of NAD
+
 is different 
when compared to BsIDH.  Furthermore, it is reported that the binding pocket of LpIDH1 
is different from that of BsIDH and the spatial orientation of the active site residues 
would generate different interactions with substrates (63). In motif V the YGY (residues 
233-235) of BsIDH is aligned with HGN of LpIDH1 and also W272 of BsIDH is aligned 
with phenylalanine in motif VI (See Figure 4.21). Furthermore, by comparing the 
structures of BsIDH and LpIDH1, it can be concluded that the active site of BsIDH looks 
wide and much solvent exposed, while the active site of LpIDH1 is closed and less 
accessible  to the substrates. 
  LpIDH1 showed 46% sequence identity with LcIDH2, which demonstrated to be 
a scyllo-inositol dehydrogenase in this research. Based on the sequences identity result 
and the previous studies on LpIDH1 showing the activity with scyllo-inosose, it was 
assumed that scyllo-inositol which is structurally related to scyllo-inosose could also be a 
possible substrate, but the experiments have demonstrated that LpIDH1 cannot oxidize 
any of the structurally related compounds except scyllo-inosose. The above mentioned 
structural features might be a possible reason for its loss of dehydrogenase activity.  
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  Based on the sequence alignment results it can be assumed that LcIDH2 may 
belong to IDH subgroup II. However, the kinetic results demonstrated that it is entirely 
different from LpIDH1 and other IDH enzymes. It also has an extra 8 amino acid residues 
before the active site in motif IV, which is similar to LpIDH1. In motif V residue Y235 is 
conserved, but in motif VI it has phenylalanine aligned with W272 of BsIDH. On the 
basis of these differences it can be assumed that LcIDH2 cannot accommodate 4-O-
substituted inositol derivatives into its active site. In this research it was observed that 
LcIDH1 is inactive with 4-O-benzyl-myo-inositol. This supports the above assumption. 
Further, dehydrogenase activity with scyllo-inositol and L-glucose suggests that LcIDH1 
may have different structural features compared to BsIDH and LcIDH1. 
   Recently, two scyllo-inositol dehydrogenases (the products of iolX and iolW) were 
identified from B. subtilis (29) and also a putative gene smc01163 was found to be 
essential for the growth of Sinorhizobium meliloti on scyllo-inositol (99). Therefore, the 
sequence of LcIDH2 was compared to protein sequences of iolX, iolW and smc01163, as 
shown in Figure 4.23. LcIDH2 demonstrated 29%, 15% and 17% sequence identity with 
the protein sequences of iolX, iolW and smc01163 respectively. The main differences in 
the sequence can be seen in α-helix1, between α-helix 7 and α-helix 8, and between α-
helix 9 and β-strand 9. In spite of having differences, all these enzymes except LpIDH1, 
are demonstrated to be scyllo-inositol dehydrogenases. 
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Figure 4.23: Multiple sequence alignment of LcIDH2 with other scyllo-inositol dehydrogenases and 
LpIDH1. BsiolX and BsiolW are from B. subtilis; SMc01163 from S. meliloti and LpIDH1 from L. 
plantarum WCFS1. The proposed active site residues are indicated with star in red. Strictly identical 
residues are highlighted in red background (for example X), similar residues are shown as red letters in 
blue frame. The secondary structural elements are assigned based in the structure of LpIDH1 (PDB code: 
3CEA).The major differences between these protein sequences are highlighted in red outline. 
 
  IDH subgroup III: LpIDH3 and IDH-related enzymes from C. glutamicum 
(CgIDH), Thermotoga maritima (TmIDH), IDHA from Rhizobium and Brucella species 
were included in this group (63). LpIDH3 demonstrated 35% and 44% sequence identity 
with CgIDH and TmIDH respectively and only 17% of sequence identity with BsIDH, 
but most of the residues in motifs I, II and III and the identified catalytic residues (K97, 
D172 and H176) are conserved. However, it was proposed that sequence motif IV has a 
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proline-rich loop before α-helix 7 (PP-II helix), a pattern associated with formation of a 
flexible left-handed helix that is often exposed to outer surfaces of proteins (66, 67). This 
flexibility suggests that PP-II helix may cause the α-helix 7 to change its position, thus 
altering the structure upon coenzyme or substrate binding (63), which is different from 
BsIDH. This may be a possible reason for the loss of activity of LpIDH3. CgIDH and 
TmIDH have same structural features, and as there is no structure available for LpIDH3, 
the structure of CgIDH was shown along with BsIDH in Figure 4.24. 
 
 
Figure 4.24: Comparison of the structures of BsIDH (PDB code: 3NT4) and CgIDH (PDB code: 
3EUW). BsIDH is on left and CgIDH is on right and the sequence motif IV is highlighted in green. 
 
  IDH subgroup IV: LpIDH4 was included in this group (63). It demonstrated low 
sequence identity of 19% with BsIDH, but it exhibited 42% identity with LpIDH3. Most 
of the residues in all the sequence motifs except motif IV are similar to group III 
members. In motif IV the amino acid residues adjacent to the conserved active site 
residues, D172 and H176 are entirely different, which may cause different interactions 
with either the nicotinamide ring of  NAD
+
 or the substrate, or may prevent the substrate 
binding. Also it can be assumed that LpIDH4 may have a structure similar to that of 
group III members.  
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5. SUMMARY OF RESEARCH AND FUTURE STUDIES 
 
 The genes encoding IDH-related enzymes from L. plantarum WCFS1 (Lp_iolG1-
Lp_iolG4) and L.casei BL23 (Lc_iolG1 & Lc_iolG2) were successfully cloned 
into pQE-80L vector. 
 All the clones, except pQE-80L-Lp_iolG2, have expressed the proteins in their 
soluble form. Expression and purification of LpIDH2 was unsuccessful as it 
resulted in the formation of insoluble inclusion bodies. However, the inclusion 
bodies were solubilized using unfolding and refolding method and purified by 
nickel affinity column chromatography. The other proteins (LpIDH1, LpIDH3, 
LpIDH4, LcIDH1 and LcIDH2) were purified by using a nickel affinity column 
chromatography.  
 IDH-related enzymes form L. plantarum WCFS1 did not exhibited any 
dehydrogenase activity, but LcIDH1 and LcIDH2 from L. casei BL23 showed 
activity with myo-inositol and other structurally related compounds. Similar to 
BsIDH, LcIDH1 and LcIDH2 are exclusively NAD
+
-dependent inositol 
dehydrogenases. The activity of LcIDH1 is similar to that of BsIDH, while 
LcIDH2 activity is different from both LcIDH1 and BsIDH. All three enzymes 
could not recognize compounds such as D-galactose, D-mannose, D-sorbitol, D-
mannitol and scyllo-inosose as substrates. LpIDH2 purified by unfolding and 
refolding method also inactive towards the compounds tested. However, BsIDH 
purified by this method showed a reduced activity. 
 pH-rate profiles of the active IDH-related enzymes were established and found  
that LpIDH1 and LcIDH2 showed maximum activity in CHES at pH 9.3 and 9.5 
respectively, while BsIDH showed maximum activity in glycine-NaOH at pH 10 
in contrast to previously reported results. 
 Kinetic experiments have demonstrated that LcIDH1 is a myo-inositol 
dehydrogenase and LcIDH2 is a scyllo-inositol dehydrogenase from L. casei 
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BL23. It is likely that LcIDH1 and LcIDH2 follows a sequentially ordered Bi-Bi 
mechanism similar to BsIDH. However, further experiments such as dead end 
inhibition and product inhibition have to be performed to understand the 
mechanism of catalysis for these enzymes. LcIDH1 and LcIDH2 catalyzed the 
oxidation of myo-inositol with much less efficiency compared to BsIDH. Further, 
LcIDH2 catalyzed the oxidation of scyllo-inositol more efficiently than myo-
inositol, while LcIDH1 and BsIDH did not show any activity at all. Further, 
experiments have to be performed to identify the product of the reactions 
catalyzed by LcIDH1 and LcIDH2. 
 By exploring the alternative substrates, it was found that LcIDH1 has a broad 
substrate spectrum and stereoselectivity similar to BsIDH, while LcIDH2 behaved 
differently compared to LcIDH1 and BsIDH. 
 Kinetic isotopic effect studies for LcIDH1 with 2-2H-myo-inositol and synthetic 
myo-inositol have demonstrated that the release of the product is primarily the 
rate-limiting step and the chemical step may be partially rate-limiting. Further 
experiments have to be performed to clearly understand whether the chemical step 
contribute to the rate-limiting or not. 
 From the multiple sequence alignment results, it can be concluded that the IDH-
related enzymes from L. plantarum WCFS1 are not active with myo-inositol and 
other related compounds because of the differences in their protein sequences. 
Furthermore, these enzymes showed low sequence identity with BsIDH. 
However, LpIDH1 was found to be active with scyllo-inosose as previously 
demonstrated in our lab. Further, it showed 46% sequence identity with LcIDH2 
but failed to oxidize scyllo-inositol.  
In this research, it was found that L. casei BL23 possesses two functionally 
different inositol dehydrogenases. LcIDH1 is a myo-inositol dehydrogenase, while 
LcIDH2 is a scyllo-inositol dehydrogenase. Although, LcIDH1exhibited 47% 
sequence identity with BsIDH and the catalytic residues are highly conserved, the 
kinetic results demonstrated that LcIDH1 is a less efficient enzyme. This enzyme 
can be assigned to IDH subgroup I.  
According to sequence alignment results, LcIDH2 can be assigned to IDH 
subgroup II. But functionally LcIDH2 can oxidize scyllo-inositol more efficiently 
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than myo-inositol and other compounds, which is different from LcIDH1 and 
BsIDH. However, the substrate spectrum is different for LcIDH2 and it is not 
clear that which hydroxyl group of scyllo-inositol, myo-inositol and other 
substrates is oxidized. Hence, future studies for LcIDH2 include identification of 
the reaction end products for the oxidation of myo-inositol and scyllo-inositol, 
crystallization experiments to identify the structural features. Furthermore site-
directed mutagenesis experiments can be performed for the conformation of 
active site residues of both LcIDH1 and LcIDH2. 
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 APPENDIX-A 
Composition of LB media, Terrific Broth and MRS Broth 
 
 
LB media 
 
Terriffic Broth 
 
MRS Broth 
Ingredients /L 
 
Ingredients /L 
 
Ingredients /L 
Tryptone 10 g 
 
Tryptone 10 g 
 
Peptone 10 g 
Yeast extract 5 g 
 
Yeast extract 5 g 
 
Meat extract 8 g 
NaCl 10 g 
 
glycerol 10 g 
 
Yeast extract 4 g 
  
pH was adjusted to 7.0 with 
5 N NaOH.  
 
KH2PO4 2.31g 
 
D(+)-glucose 20 g 
 
K2HPO4 12.54 g 
 
K2HPO4 2 g 
 
  
 
CH3COONa.3H2O 5 g 
  
Triammonium citrate 2 g 
  
MgSO4.7H2O 0.2 g 
  
MnSO4.4H2O 0.05 g 
  
Tween 80  1 mL 
All the media was sterilized by autoclaving for 15-20 min at 121
o
C or 15 psi 
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APPENDIX-B 
DNA maps of recombinant constructs 
 
A):  pQE-80L‒Lp_iolG1. Lp_iolG1 gene ligated into BamHI & PstI sites;  
B):  pQE-80L‒Lp_iolG2. Lp_iolG2 gene ligated into BamHI & SphI sites.  
 
 
 
C):  pQE-80L‒Lp_iolG3. Lp_iolG3 gene ligated into BamHI & XmaI sites;  
D):  pQE-80L‒Lp_iolG4. Lp_iolG4 gene ligated into SphI & XmaI sites. 
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E): pQE-80L‒Lc_iolG1. Lc_iolG1 gene ligated into BamHI & XmaI sites;  
F): pQE-80L‒Lc_iolG2 Lc_iolG2 gene ligated into BamHI & PstI sites.  
All the images were generated using DNADynamo software. 
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APPENDIX-C  
(True kinetics) 
Michaelis-Menten saturation curves and double-reciprocal plots (Lineweaver-Burk 
plots): 1). LcIDH1 with myo-inositol and NAD
+
: 
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A): (■) 2.5 mM, (◊) 5 mM, (▲) 10 mM, (○) 20 mM, (∆) 40 mM, and (●) 80 mM myo-inositol at different 
fixed concentrations of NAD
+
, 100 mM CHES pH 9.3 at 25 
o
C;  
B): (■) 2.5 mM, (◊) 5 mM, (▲) 10 mM, (×) 20 mM, (∆) 40 mM, and (○) 80 mM myo-inositol at different 
fixed concentrations of NAD
+
, 100 mM CHES pH 9.3 at 25 
o
C;  
C): (●) 0.25 mM, (□) 0.5 mM, (▲) 1.0 mM, (◊) 2.0 mM, and (■) 3.0 mM NAD+ at different fixed 
concentrations of myo-inositol, 100 mM CHES pH 9.3 at 25 
o
C.  
D): (■) 0.25 mM, (◊) 0.5 mM, (∆) 1.0 mM, (●) 2.0 mM, and (□) 3.0 mM NAD+ at different fixed 
concentrations of myo-inositol, 100 mM CHES pH 9.3 at 25 
o
C. 
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2). LcIDH1 with D-glucose and NAD
+
: 
 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0.0 0.5 1.0 1.5 2.0 2.5
R
a
te
 (
µ
M
/s
)
[NAD+] (mM)
LcIDH1 with D-glucose
-10
0
10
20
30
40
50
60
70
-2 0 2 4 6 8 10 12 14
1
/R
a
te
 (
µ
M
/s
)
1/[NAD+](mM)
Lineweaver-Burk plot 
(LcIDH1 with D-glucose)
 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0 100 200 300 400 500 600 700
R
a
te
 (
µ
M
/s
)
[D-glucose] (mM)
LcIDH1 with NAD+
-20
-10
0
10
20
30
40
50
60
70
-0.03 -0.01 0.01 0.03 0.05 0.07 0.09 0.11 0.13
1
/R
a
te
 (
µ
M
/s
)
1/[D-glucose](mM)
Lineweaver-Burk plot 
(LcIDH1 with NAD+)
 
 
A): (■) 10 mM, (□) 20 mM, (♦) 40 mM, (∆) 80 mM, (▲) 150 mM, (×) 300 mM and (○) 600 mM D-glucose 
at different fixed concentrations of NAD
+
, 100 mM CHES pH 9.3 at 25 
o
C.  
B): (■) 10 mM, (□) 20 mM, (♦) 40 mM, (▲) 80 mM, (∆) 150 mM, (×) 300 mM and (○) 600 mM D-glucose 
at different fixed concentrations of NAD
+
, 100 mM CHES pH 9.3 at 25 
o
C.  
C): (●) 0.1 mM, (○) 0.25 mM, (▲) 0.5 mM, (◊) 1.0 mM, and (■) 2.0 mM NAD+ at different fixed 
concentrations of D-glucose, 100 mM CHES pH 9.3 at 25 
o
C.  
D): (■) 0.1 mM, (♦) 0.25 mM, (○) 0.5 mM, (▲) 1.0 mM, and (●) 2.0 mM NAD+ at different fixed 
concentrations of D-glucose, 100 mM CHES pH 9.3 at 25 
o
C. 
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3). LcIDH2 with myo-inositol and NAD
+
: 
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A):  (○) 2.5 mM, (◊) 5 mM, (×) 10 mM, (▲) 20 mM, (□) 40 mM, and (●) 80 mM myo-inositol at different 
fixed concentrations of NAD
+
, 100 mM CHES pH 9.5 at 25 
o
C.  
 
B):  (●) 2.5 mM, (□) 5 mM, (▲) 10 mM, (×) 20 mM, (○) 40 mM, and (♦) 80 mM myo-inositol at different 
fixed concentrations of NAD
+
, 100 mM CHES pH 9.5 at 25 
o
C.  
 
C): (∆) 0.1 mM, (×) 0.2 mM, (●) 0.5 mM, (◊) 1.0 mM, and (■) 2.0 mM NAD+ at different fixed 
concentrations of myo-inositol, 100 mM CHES pH 9.5 at 25 
o
C.  
 
D): (■) 0.1 mM, (◊) 0.2 mM, (▲) 0.5 mM, (×) 1.0 mM, and (○) 2.0 mM NAD+ at different fixed 
concentrations of NAD
+
, 100 mM CHES pH 9.5 at 25 
o
C. 
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4). LcIDH2 with scyllo-inositol and NAD
+
: 
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A):  (●) 0.1 mM, (□) 0.2 mM, (▲) 0.5 mM, (◊) 1 mM, and (×) 2 mM scyllo-inositol at different fixed 
concentrations of NAD
+
, 100 mM CHES pH 9.5 at 25 
o
C.  
 
B):  (●) 0.1 mM, (■) 0.2 mM, (▲) 0.5 mM, (♦) 1 mM, and (×) 2 mM scyllo-inositol at different fixed 
concentrations of NAD
+
, 100 mM CHES pH 9.5 at 25 
o
C.  
 
C): (∆) 0.1 mM, (×) 0.25 mM, (●) 0.5 mM, (◊) 1 mM, and (■) 1.5 mM NAD+ at different fixed 
concentrations of scyllo-inositol, 100 mM CHES pH 9.5 at 25 
o
C.  
 
D): (■) 0.1 mM, (◊) 0.25 mM, (▲) 0.5 mM, (×) 1.0 mM, and (○) 1.5 mM NAD+ at different fixed 
concentrations of NAD
+
, 100 mM CHES pH 9.5 at 25 
o
C. 
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5). BsIDH with myo-inositol and NAD
+
: 
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A): (×) 1 mM, (□) 5 mM, (♦) 10 mM, (∆) 20 mM, and (●) 50 mM myo-inositol at different fixed 
concentrations of NAD
+
, 100 mM glycine-NaOH pH 10 at 25 
o
C.  
B): (■) 1 mM, (◊) 5 mM, (●) 10 mM, (∆) 20 mM, and (×) 50 mM myo-inositol at different fixed 
concentrations of NAD
+
, 100 mM glycine-NaOH pH 10 at 25 
o
C.  
C): (■) 0.1 mM, (◊) 0.25 mM, (▲) 0.5 mM, (○) 1.0 mM, and (●) 2.0 mM NAD+ at different fixed 
concentrations of myo-inositol, 100 mM glycine-NaOH pH 10 at 25 
o
C.  
D): (●) 0.1 mM, (▲) 0.25 mM, (■) 0.5 mM, (♦) 1.0 mM, and (○) 2.0 mM NAD+ at different fixed 
concentrations of NAD
+
, 100 mM glycine-NaOH pH 10 at 25 
o
C. 
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APPENDIX-D 
(Apparent kinetics) 
Michaelis-Menten saturation curves and double-reciprocal plots (Lineweaver-Burk 
plots): 1). LcIDH1 with different substrates at 2mM NAD
+ 
and100 mM CHES pH 
9.3 at 25 
o
C: 
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A): 2.5, 5 10, 20, 40, and 80 mM myo-inositol; 
B): 1, 2.5, 5, 10, 20, 40, 60, 80, and 100 mM D-chiro-inositol;  
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C): 10, 20, 40, 80, 150, and 300 mM D-glucose;  
D): 10, 25, 50, 100, 150, 200, 400, 600, 1000 mM D-xylose and  
E): 20, 40, 60, 80, 100, 120 mM 4-O-benzyl-myo-inositol  
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2). LcIDH2 with different substrates at 2mM NAD
+ 
and100 mM CHES pH 9.5 at 
25
o
C: 
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A): 2.5, 5 10, 20, 40, 80, and 160 mM myo-inositol;  
B): 50, 100, 200, 400, and 600 mM D-chiro-inositol;  
C): 0.1, 0.2, 0.5, 1, 2, and 5 mM scyllo-inositol;  
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D): 10, 25, 50, 100, 200, and 400 D-glucose;  
E): 10, 25, 50, 100, 200, and 400 L-glucose;  
F): 5, 10, 25, 50, 100, 200, 400, and 800 mM D-xylose  
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3). BsIDH with different substrates at 2mM NAD
+ 
and100 mM glycine-NaOH pH 10 
at 25
o
C: 
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A): 1, 5 10, 20, and 50 mM myo-inositol;  
B): 2.5, 5, 10, 20, 40, 80, 160, and 320 mM D-chiro-inositol;  
 
96 
 
0
100
200
300
400
500
600
700
0 50 100 150 200 250
R
a
te
 (
n
M
/s
)
[D-glucose] (mM)
BsIDH with D-glucose
-0.010
-0.005
0.000
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
-0.10 -0.05 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35
1
/R
a
te
 (
n
M
/s
)
1/[D-glucose] (mM)
BsIDH with D-glucose
 
 
0
100
200
300
400
500
600
700
800
900
1000
0 100 200 300 400 500 600 700 800
R
a
te
 (
n
M
/s
)
[D-xylose] (mM)
BsIDH with D-xylose
-0.002
0.000
0.002
0.004
0.006
0.008
0.010
-0.02 -0.01 0 0.01 0.02 0.03 0.04 0.05 0.06
1
/R
a
te
 (
n
M
/s
)
1/[D-Xylose] (mM)
Lineweaver-Burk plot 
(BsIDH with D-xylose)
 
 
0
50
100
150
200
250
300
350
400
0 20 40 60 80 100 120 140 160
R
a
te
 (
n
M
/s
)
[4-O-benzyl-myo-inositol] (mM)
BsIDH with 4-O-benzyl-myo-inositol
-0.002
0.000
0.002
0.004
0.006
0.008
0.010
0.012
0.014
0.016
0.018
-0.10 -0.05 0.00 0.05 0.10 0.15 0.20 0.25
1
/R
a
te
 (
n
M
/s
)
1/[4-O-benzyl-myo-inositol] (mM)
Lineweaver-Burk plot 
(BsIDH with 4-O-benzyl-myo-inositol)
 
 
C): 5, 10, 20, 40, 80, and 150 mM D-glucose;  
D): 25, 50, 100, 200, 400, and 600 mM D-xylose  
E): 5, 10, 20, 40, 80, and 120 mM 4-O-benzyl-myo-inositol  
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APPENDIX-E 
(Kinetics isotopic effect) 
Michaelis-Menten saturation curves and double-reciprocal plots (Lineweaver-Burk 
plots): 1). LcIDH1 with 2-
2
H-myo-inositol and 2-
1
H-myo-inositol at 2mM NAD
+ 
and100 mM CHES pH 9.3 at 25 
o
C: 
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A): 2.5, 5 10, 20, 40, and 80 mM 2-
2
H-myo-inositol and 
B): 2.5, 5 10, 20, 40, and 80 mM 2-
1
H-myo-inositol (synthetic myo-inositol) 
 
 
